Category	Term	Count	%	PValue	Genes	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
GOTERM_CC_DIRECT	GO:0070062~extracellular exosome	40	46.51162790697674	1.86370555896378E-16	5641, 59342, 2194, 83706, 1514, 57447, 83758, 3959, 730, 2588, 335, 336, 2244, 2266, 338, 635, 7018, 3698, 2628, 5858, 7057, 5176, 5232, 5476, 2243, 26007, 1291, 4060, 81027, 10404, 1522, 2335, 3248, 348, 4059, 54504, 5105, 51733, 727, 4758	85	2241	20521	4.309210699005171	3.064215547965432E-14	2.5719136713700164E-14	2.1618984483979848E-14
GOTERM_CC_DIRECT	GO:0005576~extracellular region	38	44.18604651162791	3.8078466241840515E-15	9388, 6694, 5641, 2331, 83706, 10437, 1514, 3959, 730, 2588, 335, 336, 2267, 2244, 2266, 338, 7018, 4148, 3698, 5858, 7057, 5176, 5476, 2243, 1291, 4060, 116519, 383, 341, 344, 1522, 2335, 348, 4059, 4018, 727, 5648, 4758	85	2172	20521	4.223800238327375	5.209166431541234E-13	2.627414170686996E-13	2.2085510420267498E-13
GOTERM_CC_DIRECT	GO:0005788~endoplasmic reticulum lumen	16	18.6046511627907	2.0138832028099076E-12	6694, 7057, 2243, 116519, 1291, 1522, 2335, 335, 336, 2266, 348, 338, 7018, 4148, 3698, 2719	85	310	20521	12.46056925996205	2.7790902912272486E-10	9.263862732925575E-11	7.787015050864975E-11
REACTOME_PATHWAY	R-HSA-8957275~Post-translational protein phosphorylation	13	15.11627906976744	3.245236499333302E-12	6694, 2243, 116519, 2335, 335, 336, 2266, 348, 338, 7018, 4148, 3698, 2719	72	108	11044	18.463477366255145	1.395428217421113E-9	8.704631037992734E-10	7.773437950207465E-10
REACTOME_PATHWAY	R-HSA-1430728~Metabolism	41	47.674418604651166	4.048665599066388E-12	5264, 5641, 130013, 2331, 2194, 1558, 2328, 122622, 1610, 2588, 335, 11309, 336, 3158, 338, 55902, 635, 6822, 2628, 8529, 32, 5053, 5232, 5476, 63874, 26007, 4060, 116519, 383, 57733, 344, 3248, 3422, 27232, 348, 5424, 5105, 84498, 51733, 2719, 4758	72	2127	11044	2.956720472235282	1.74091963067724E-9	8.704631037992734E-10	7.773437950207465E-10
GOTERM_CC_DIRECT	GO:0042627~chylomicron	7	8.13953488372093	1.147394818195081E-11	341, 344, 335, 336, 348, 338, 116519	85	14	20521	120.71176470588236	1.5834027422556574E-9	3.95851212277303E-10	3.327444972765735E-10
REACTOME_PATHWAY	R-HSA-381426~Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	13	15.11627906976744	1.8837162111548885E-11	6694, 2243, 116519, 2335, 335, 336, 2266, 348, 338, 7018, 4148, 3698, 2719	72	125	11044	15.952444444444444	8.099976245290463E-9	2.699993235988674E-9	2.4111567502782573E-9
GOTERM_CC_DIRECT	GO:0005577~fibrinogen complex	6	6.976744186046512	5.648931122540103E-11	7057, 2335, 2267, 2244, 2266, 2243	85	8	20521	181.06764705882352	7.795517564801457E-9	1.5591049898210684E-9	1.310552020429304E-9
GOTERM_CC_DIRECT	GO:0034361~very-low-density lipoprotein particle	7	8.13953488372093	2.0265187063052403E-10	341, 344, 335, 336, 348, 338, 116519	85	21	20521	80.47450980392156	2.7965961213460844E-8	4.660993024502052E-9	3.917936165523465E-9
GOTERM_CC_DIRECT	GO:0043202~lysosomal lumen	10	11.627906976744185	2.4333065842181107E-10	10437, 1514, 2588, 5476, 5641, 338, 2331, 2719, 4758, 4060	85	98	20521	24.635054021608642	3.357963451744439E-8	4.797090123172847E-9	4.032336625275727E-9
GOTERM_CC_DIRECT	GO:0072562~blood microparticle	11	12.790697674418606	4.5879427495039537E-10	3959, 2335, 335, 336, 2244, 2266, 348, 2243, 7018, 3698, 5858	85	147	20521	18.065706282513005	6.331360102862504E-8	7.91420124289432E-9	6.652516986780733E-9
UP_KW_DOMAIN	KW-0732~Signal	44	51.162790697674424	5.132947023272669E-10	9388, 6694, 5641, 59342, 2331, 10437, 1558, 1514, 3959, 730, 2588, 335, 11309, 336, 2267, 23142, 2244, 2266, 338, 7018, 4148, 3698, 8529, 5858, 7057, 5176, 5476, 2243, 1291, 4060, 116519, 341, 10404, 344, 1522, 2335, 348, 4059, 54504, 2719, 4018, 727, 5648, 4758	64	4412	14600	2.275045330915684	8.21271584072747E-9	8.21271523723627E-9	8.21271523723627E-9
UP_KW_CELLULAR_COMPONENT	KW-0964~Secreted	32	37.2093023255814	7.991450423139475E-10	9388, 6694, 59342, 2331, 2671, 10437, 1514, 3959, 730, 335, 336, 2267, 2244, 2266, 338, 7018, 4148, 3698, 5858, 7057, 5176, 2243, 1291, 4060, 116519, 341, 10404, 344, 2335, 348, 727, 5648	80	2174	17910	3.2953081876724934	2.397435217016408E-8	2.3974351269418426E-8	1.8380335973220793E-8
REACTOME_PATHWAY	R-HSA-8963899~Plasma lipoprotein remodeling	8	9.30232558139535	1.571421986779047E-9	9388, 344, 335, 336, 348, 338, 4018, 116519	72	34	11044	36.091503267973856	6.757112290811662E-7	1.6892786357874754E-7	1.508565107307885E-7
GOTERM_BP_DIRECT	GO:0033700~phospholipid efflux	6	6.976744186046512	1.75315561077099E-9	341, 344, 335, 336, 348, 116519	85	13	19256	104.55746606334841	1.4147955863519357E-6	1.2662773365263018E-6	1.2176347126944365E-6
REACTOME_PATHWAY	R-HSA-8963901~Chylomicron remodeling	6	6.976744186046512	2.3394104037335413E-9	344, 335, 336, 348, 338, 116519	72	10	11044	92.03333333333333	1.0059459857325592E-6	2.0118929472108454E-7	1.7966671900673598E-7
GOTERM_BP_DIRECT	GO:0033344~cholesterol efflux	7	8.13953488372093	3.1382337956042177E-9	341, 344, 335, 336, 348, 338, 116519	85	30	19256	52.859607843137255	2.532551460654453E-6	1.2662773365263018E-6	1.2176347126944365E-6
GOTERM_MF_DIRECT	GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity	5	5.813953488372093	5.17011001362787E-9	341, 335, 336, 348, 116519	84	6	18883	187.33134920634922	1.3235472893224909E-6	1.3235481634887346E-6	1.2408264032706887E-6
GAD_DISEASE	atherosclerosis	15	17.441860465116278	8.563612668381978E-9	9388, 7057, 2243, 116519, 344, 335, 336, 2244, 2266, 348, 338, 635, 5105, 4018, 727	76	343	12924	7.436704004910235	1.1449484693559775E-5	7.979012069635145E-6	7.424002254768976E-6
GAD_DISEASE	Type 2 diabetes	15	17.441860465116278	1.3733303603348745E-8	9388, 2243, 116519, 341, 1558, 344, 335, 336, 2244, 348, 338, 55902, 54504, 727, 32	76	356	12924	7.1651389710230635	1.8361258476540243E-5	7.979012069635145E-6	7.424002254768976E-6
GAD_DISEASE	plasma HDL cholesterol (HDL-C) levels	13	15.11627906976744	1.7903542415037722E-8	2194, 116519, 344, 3248, 335, 336, 3158, 3422, 348, 338, 55902, 5105, 4018	76	249	12924	8.878249841471147	2.393674994971562E-5	7.979012069635145E-6	7.424002254768976E-6
REACTOME_PATHWAY	R-HSA-174824~Plasma lipoprotein assembly, remodeling, and clearance	9	10.465116279069768	2.3310551319041877E-8	341, 9388, 344, 335, 336, 348, 338, 4018, 116519	72	75	11044	18.406666666666666	1.0023486926136194E-5	1.6705895111980013E-6	1.4918752844186801E-6
UP_KW_BIOLOGICAL_PROCESS	KW-0443~Lipid metabolism	18	20.930232558139537	2.4559015747994066E-8	9388, 63874, 2330, 2194, 1558, 57733, 344, 3248, 335, 3158, 3422, 348, 338, 55902, 6822, 8529, 4758, 32	54	756	11447	5.0471781305114645	1.3998629327938161E-6	1.3998638976356617E-6	1.1297147244077272E-6
GOTERM_CC_DIRECT	GO:0005615~extracellular space	27	31.3953488372093	2.7281711475747354E-8	9388, 2331, 2671, 1514, 3959, 730, 335, 2267, 2244, 2266, 338, 7018, 5858, 7057, 5176, 2243, 4060, 116519, 383, 10404, 344, 1522, 2335, 348, 4018, 727, 5648	85	1931	20521	3.3756785572851613	3.764869143663141E-6	4.183195759614594E-7	3.5163094790963257E-7
KEGG_PATHWAY	hsa04979:Cholesterol metabolism	8	9.30232558139535	4.874079916908874E-8	341, 9388, 344, 335, 336, 348, 338, 4018	61	51	8662	22.27450980392157	6.092581485428461E-6	6.092599896136092E-6	5.848895900290648E-6
GOTERM_CC_DIRECT	GO:0034364~high-density lipoprotein particle	6	6.976744186046512	5.074599723176417E-8	341, 344, 335, 336, 348, 116519	85	25	20521	57.94164705882353	7.002923268273342E-6	7.002947617983455E-7	5.886535678884643E-7
WIKIPATHWAYS	WP5304:Cholesterol metabolism	9	10.465116279069768	5.1374892285798817E-8	341, 9388, 344, 335, 336, 3422, 348, 338, 4018	64	72	8414	16.43359375	1.0634546440457804E-5	7.978803292710186E-6	7.284994310735387E-6
WIKIPATHWAYS	WP430:Statin inhibition of cholesterol production	7	8.13953488372093	8.790973696480619E-8	341, 344, 335, 336, 348, 338, 116519	64	31	8414	29.686491935483872	1.8197150775112192E-5	7.978803292710186E-6	7.284994310735387E-6
REACTOME_PATHWAY	R-HSA-8963898~Plasma lipoprotein assembly	6	6.976744186046512	1.0320475434735137E-7	341, 344, 335, 336, 348, 338	72	19	11044	48.43859649122807	4.4377061947264984E-5	6.339720624194441E-6	5.66151795276899E-6
GAD_DISEASE	Cardiovascular Diseases|	8	9.30232558139535	1.0968290680368917E-7	341, 2244, 2266, 348, 338, 2243, 7018, 116519	76	67	12924	20.304791830322074	1.4663530236946887E-4	2.8048542463198608E-5	2.6097521932848965E-5
WIKIPATHWAYS	WP4522:Metabolic pathway of LDL HDL and TG including diseases	6	6.976744186046512	1.1563483032913312E-7	9388, 344, 335, 336, 348, 338	64	17	8414	46.400735294117645	2.3936124798562552E-5	7.978803292710186E-6	7.284994310735387E-6
GAD_DISEASE	myocardial infarction	8	9.30232558139535	1.2170649184734516E-7	2244, 2266, 348, 338, 2243, 4018, 8529, 383	76	68	12924	20.006191950464398	1.6270835111209525E-4	2.8048542463198608E-5	2.6097521932848965E-5
REACTOME_PATHWAY	R-HSA-114608~Platelet degranulation 	10	11.627906976744185	1.235902179178301E-7	7057, 6694, 3959, 2335, 335, 2244, 2266, 2243, 7018, 83706	72	129	11044	11.890611541774334	5.314238489539935E-5	6.6429742130833685E-6	5.932330460055845E-6
GAD_DISEASE	Chronic renal failure|Kidney Failure, Chronic	21	24.418604651162788	1.2587229228062202E-7	9388, 7057, 2330, 26007, 2194, 116519, 1558, 2328, 122622, 2335, 11309, 336, 3158, 2244, 2266, 348, 338, 635, 5424, 6822, 8529	76	903	12924	3.9547123623011022	1.682771051570997E-4	2.8048542463198608E-5	2.6097521932848965E-5
GAD_DISEASE	Type 2 Diabetes| edema | rosiglitazone	33	38.372093023255815	1.5172366546228834E-7	9388, 2194, 23523, 1558, 730, 335, 336, 3158, 2267, 2244, 2266, 338, 55902, 635, 7018, 8529, 7057, 5176, 2243, 4060, 116519, 383, 341, 344, 2335, 3248, 56288, 348, 5424, 5105, 51733, 4018, 727	76	2198	12924	2.5531104832144056	2.0283398244669293E-4	2.8979220103297074E-5	2.6963462833583815E-5
UP_KW_CELLULAR_COMPONENT	KW-0850~VLDL	5	5.813953488372093	1.689416274004782E-7	341, 344, 348, 338, 116519	80	12	17910	93.28125	5.06823640522569E-6	2.5341244110071733E-6	1.9428287151054996E-6
REACTOME_PATHWAY	R-HSA-76005~Response to elevated platelet cytosolic Ca2+	10	11.627906976744185	1.7151469501723587E-7	7057, 6694, 3959, 2335, 335, 2244, 2266, 2243, 7018, 83706	72	134	11044	11.4469320066335	7.37486056134884E-5	8.194590984156825E-6	7.317960320735397E-6
GAD_DISEASE	Alzheimer's disease   	21	24.418604651162788	2.8657734349462273E-7	5264, 2243, 116519, 1291, 341, 1558, 3437, 3248, 56288, 3434, 3433, 3158, 2244, 2266, 348, 338, 7018, 5105, 3698, 5858, 32	76	950	12924	3.7590581717451523	3.830805690853145E-4	4.7894238531538826E-5	4.4562776913413836E-5
REACTOME_PATHWAY	R-HSA-8963888~Chylomicron assembly	5	5.813953488372093	3.1987930394858806E-7	344, 335, 336, 348, 338	72	10	11044	76.69444444444446	1.3753866338162002E-4	1.3754810069789287E-5	1.2283365271625781E-5
GAD_DISEASE	myocardial infarct	9	10.465116279069768	4.6732413405527387E-7	1558, 9388, 7057, 335, 2244, 2266, 348, 2243, 4018	76	121	12924	12.648542844715093	6.246173585379156E-4	6.942359635910013E-5	6.459458030719563E-5
WIKIPATHWAYS	WP5115:Network map of SARS CoV 2 signaling pathway	12	13.953488372093023	5.175011419984394E-7	341, 1514, 3959, 1522, 2335, 3434, 335, 336, 2244, 2266, 2243, 7018	64	218	8414	7.236811926605505	1.0711702668397827E-4	2.399230546483285E-5	2.1906018033108254E-5
WIKIPATHWAYS	WP3601:Lipid particles composition	5	5.813953488372093	5.795242865901655E-7	344, 335, 336, 348, 338	64	10	8414	65.734375	1.1995436697764816E-4	2.399230546483285E-5	2.1906018033108254E-5
GAD_DISEASE	cholesterol; coronary heart disease; lipoproteins	4	4.651162790697675	7.477681767689488E-7	341, 344, 348, 4018	76	4	12924	170.05263157894737	9.992668262640558E-4	9.997660523400845E-5	9.302236119005724E-5
GOTERM_BP_DIRECT	GO:0034375~high-density lipoprotein particle remodeling	5	5.813953488372093	7.679186841905902E-7	341, 9388, 335, 336, 348	85	17	19256	66.62975778546713	6.19518635126326E-4	1.9853127010884022E-4	1.9090491400800498E-4
UP_SEQ_FEATURE	CARBOHYD:N-linked (GlcNAc...) (complex) asparagine	8	9.30232558139535	7.7409577528727E-7	3959, 5176, 730, 2335, 2266, 7018, 3698, 5648	84	126	20562	15.541950113378684	4.3494737702998165E-4	4.350418257114457E-4	4.334936341608712E-4
GOTERM_BP_DIRECT	GO:0043691~reverse cholesterol transport	5	5.813953488372093	9.84045948494871E-7	9388, 344, 335, 336, 348	85	18	19256	62.928104575163395	7.93810236989767E-4	1.9853127010884022E-4	1.9090491400800498E-4
UP_KW_CELLULAR_COMPONENT	KW-0345~HDL	5	5.813953488372093	1.2921769803590276E-6	344, 335, 336, 348, 116519	80	19	17910	58.91447368421052	3.876458308915698E-5	1.2921769803590276E-5	9.906690182752546E-6
GAD_DISEASE	cholesterol cholesterol, HDL cholesterol, LDL lipoprotein triglycerides	5	5.813953488372093	1.3603764648072649E-6	341, 344, 335, 348, 116519	76	15	12924	56.684210526315795	0.0018171715115444798	1.5405365588315643E-4	1.433378817641336E-4
GAD_DISEASE	Cardiovascular Diseases	10	11.627906976744185	1.3826805314868192E-6	341, 9388, 344, 335, 2244, 348, 338, 4059, 4018, 116519	76	189	12924	8.997493734335839	0.001846937456702391	1.5405365588315643E-4	1.433378817641336E-4
GOTERM_MF_DIRECT	GO:0004866~endopeptidase inhibitor activity	6	6.976744186046512	1.5456149886238845E-6	7057, 6694, 3698, 4018, 727, 5858	84	45	18883	29.973015873015875	3.9559947276590623E-4	1.978387185438572E-4	1.8547379863486613E-4
GAD_DISEASE	Hypercholesterolemia|LDLC levels	10	11.627906976744185	1.6455513537316228E-6	1558, 9388, 1610, 335, 336, 348, 338, 5105, 2194, 32	76	193	12924	8.81101718025634	0.002197685515338943	1.6790427420999452E-4	1.5622506889845412E-4
GAD_DISEASE	Diseases in Twins|Obstetric Labor, Premature	5	5.813953488372093	1.8058717361101292E-6	344, 335, 348, 338, 116519	76	16	12924	53.14144736842105	0.0024115402448882106	1.6790427420999452E-4	1.5622506889845412E-4
GOTERM_BP_DIRECT	GO:0070527~platelet aggregation	6	6.976744186046512	1.8600967985053886E-6	81027, 2267, 2244, 2266, 2243, 83706	85	47	19256	28.92015018773467	0.0014999734261208486	2.358259625921436E-4	2.267669727032261E-4
GAD_DISEASE	LDL cholesterol	6	6.976744186046512	1.8837427921839324E-6	341, 344, 335, 348, 338, 116519	76	36	12924	28.342105263157894	0.002515397557706467	1.6790427420999452E-4	1.5622506889845412E-4
GOTERM_BP_DIRECT	GO:0042157~lipoprotein metabolic process	5	5.813953488372093	1.9055746819154774E-6	341, 335, 336, 348, 116519	85	21	19256	53.938375350140056	0.0015366184246143888	2.358259625921436E-4	2.267669727032261E-4
GOTERM_BP_DIRECT	GO:0008203~cholesterol metabolic process	7	8.13953488372093	2.0455783620136372E-6	341, 335, 336, 348, 338, 6822, 116519	85	86	19256	18.43939808481532	0.0016494216330474876	2.358259625921436E-4	2.267669727032261E-4
GAD_DISEASE	lipids	5	5.813953488372093	2.3511576934013117E-6	335, 336, 348, 338, 116519	76	17	12924	50.015479876160995	0.0031385659036781144	1.9646861475484712E-4	1.82802510661952E-4
GAD_DISEASE	Coronary Disease|Coronary heart disease	7	8.13953488372093	2.5657263976474387E-6	341, 344, 2267, 348, 338, 4018, 116519	76	68	12924	17.50541795665635	0.0034245035609644647	2.017868349208603E-4	1.8775080227490667E-4
GOTERM_BP_DIRECT	GO:0034384~high-density lipoprotein particle clearance	4	4.651162790697675	2.767706489006606E-6	344, 335, 336, 348	85	7	19256	129.45210084033613	0.002231049728118717	2.791923920785414E-4	2.684675294336408E-4
GAD_DISEASE	Hyperlipidemias	6	6.976744186046512	3.6609711189459743E-6	1558, 344, 335, 336, 348, 338	76	41	12924	24.885750962772786	0.004882767688883072	2.670826379931568E-4	2.485047132860786E-4
GAD_DISEASE	lipoprotein	5	5.813953488372093	3.795489993919207E-6	341, 335, 348, 338, 4018	76	19	12924	44.75069252077562	0.005061725824314411	2.670826379931568E-4	2.485047132860786E-4
REACTOME_PATHWAY	R-HSA-556833~Metabolism of lipids	18	20.930232558139537	4.28596082220685E-6	5264, 5476, 5641, 63874, 2194, 116519, 1558, 57733, 3248, 335, 336, 3158, 3422, 84498, 6822, 8529, 4758, 32	72	758	11044	3.6424802110817946	0.001841269881941332	1.6754210486808597E-4	1.4961899597522093E-4
GAD_DISEASE	heart disease, ischemic	6	6.976744186046512	4.660230478721407E-6	1558, 2335, 2244, 348, 338, 116519	76	43	12924	23.728274173806607	0.006211371843752755	3.0073222655664303E-4	2.7981367975801345E-4
GAD_DISEASE	Cholesterol, total	5	5.813953488372093	4.723542825497011E-6	9388, 335, 348, 338, 116519	76	20	12924	42.51315789473684	0.006295491501782657	3.0073222655664303E-4	2.7981367975801345E-4
GAD_DISEASE	cholesterol	5	5.813953488372093	5.809362269516181E-6	341, 335, 348, 338, 116519	76	21	12924	40.48872180451128	0.007737053629459423	3.5305078883377883E-4	3.2849303014900586E-4
WIKIPATHWAYS	WP2806:Complement system	8	9.30232558139535	6.1845739778720755E-6	7057, 730, 335, 2244, 2266, 2243, 727, 5648	64	95	8414	11.071052631578947	0.0012793916519694415	2.133678022365866E-4	1.9481408030297038E-4
GOTERM_BP_DIRECT	GO:0042632~cholesterol homeostasis	7	8.13953488372093	6.924547418286355E-6	9388, 344, 335, 336, 348, 338, 116519	85	106	19256	14.960266370699221	0.0055725445636838344	6.209010851730099E-4	5.970498662878014E-4
GAD_DISEASE	Hypertriglyceridemia	5	5.813953488372093	7.069180990441632E-6	9388, 335, 348, 338, 116519	76	22	12924	38.64832535885167	0.00940700308492981	4.109345645313244E-4	3.823504848743213E-4
GOTERM_BP_DIRECT	GO:0007160~cell-matrix adhesion	7	8.13953488372093	7.713733726344712E-6	2335, 2267, 2244, 2266, 2243, 4059, 83706	85	108	19256	14.68322440087146	0.006205671910757937	6.224983117160183E-4	5.985857371643496E-4
REACTOME_PATHWAY	R-HSA-975634~Retinoid metabolism and transport	6	6.976744186046512	8.509297396736638E-6	344, 335, 336, 348, 338, 2719	72	44	11044	20.916666666666664	0.003652327415962331	3.0491649004972955E-4	2.722975166955724E-4
GOTERM_CC_DIRECT	GO:0031093~platelet alpha granule lumen	6	6.976744186046512	8.673783526846577E-6	7057, 2335, 2244, 2266, 2243, 83706	85	68	20521	21.302076124567474	0.0011962712143510634	1.0881655697316614E-4	9.146898991947298E-5
UP_KW_BIOLOGICAL_PROCESS	KW-0753~Steroid metabolism	7	8.13953488372093	9.310312388894562E-6	1558, 335, 3158, 3422, 348, 338, 6822	54	107	11447	13.867947386638974	5.305494854408455E-4	2.65343903083495E-4	2.141371849445749E-4
UP_KW_CELLULAR_COMPONENT	KW-0162~Chylomicron	4	4.651162790697675	9.693760255772287E-6	344, 348, 338, 116519	80	10	17910	89.55	2.907719348600457E-4	7.270320191829216E-5	5.573912147069065E-5
GAD_DISEASE	cardiovascular disease risk	4	4.651162790697675	1.029493694372638E-5	2244, 2266, 348, 2243	76	8	12924	85.02631578947368	0.013670105310281233	5.735137789067571E-4	5.336208982498174E-4
GAD_DISEASE	cardiovascular disease	6	6.976744186046512	1.0969243881289796E-5	81027, 341, 335, 348, 338, 116519	76	51	12924	20.006191950464398	0.014558938151688294	5.866351627713783E-4	5.458295755329803E-4
INTERPRO	IPR029058:AB_hydrolase	7	8.13953488372093	1.3068616745909722E-5	9388, 57447, 5476, 63874, 59342, 54504, 2194	86	125	20603	13.415906976744187	0.004758717535470414	0.003673959943414435	0.0036035004376503226
REACTOME_PATHWAY	R-HSA-6806667~Metabolism of fat-soluble vitamins	6	6.976744186046512	1.3151918944878796E-5	344, 335, 336, 348, 338, 2719	72	48	11044	19.17361111111111	0.0056394008777027604	4.350250112536833E-4	3.88487451910266E-4
GOTERM_MF_DIRECT	GO:0005201~extracellular matrix structural constituent	7	8.13953488372093	1.3362729303769816E-5	7057, 2335, 2244, 2266, 2243, 4148, 4060	84	118	18883	13.33545197740113	0.003415037009052657	0.001140286233921691	0.0010690183443015852
KEGG_PATHWAY	hsa01100:Metabolic pathways	26	30.23255813953488	1.3442789035308432E-5	9388, 130013, 2330, 2194, 1558, 2328, 122622, 1610, 2588, 3158, 55902, 635, 2628, 8529, 2329, 32, 5053, 5232, 26007, 383, 57733, 3422, 27232, 5105, 51733, 4758	61	1546	8662	2.388098318240621	0.0016789489095054844	8.40174314706777E-4	8.06567342118506E-4
GAD_DISEASE	lipid levels	5	5.813953488372093	1.419581060338366E-5	341, 335, 348, 338, 116519	76	26	12924	32.702429149797574	0.01880094871885285	7.29992260643229E-4	6.792149381003567E-4
UP_KW_PTM	KW-0873~Pyrrolidone carboxylic acid	7	8.13953488372093	1.4567062651117182E-5	5176, 2335, 336, 2244, 2331, 2719, 4060	75	102	14237	13.027320261437909	3.349887600233581E-4	3.4960950362681237E-4	3.059083156734608E-4
UP_KW_BIOLOGICAL_PROCESS	KW-0445~Lipid transport	8	9.30232558139535	1.4750511359450858E-5	341, 344, 335, 336, 348, 338, 4018, 116519	54	175	11447	9.69058201058201	8.404319875509048E-4	2.802597158295663E-4	2.2617450751157982E-4
REACTOME_PATHWAY	R-HSA-216083~Integrin cell surface interactions	7	8.13953488372093	1.66949875937561E-5	7057, 2335, 2244, 2266, 2243, 1291, 4060	72	85	11044	12.63202614379085	0.007153197808057454	5.127746189510802E-4	4.57919659714453E-4
GAD_DISEASE	Brain Ischemia|Stroke	7	8.13953488372093	1.9116948360065664E-5	2244, 348, 338, 2243, 7018, 727, 116519	76	96	12924	12.399671052631579	0.025235722878031996	9.466429613854738E-4	8.807956948119144E-4
GAD_DISEASE	Coronary Disease|Coronary heart disease|Inflammation|Insulin Resistance	6	6.976744186046512	2.2549448788769928E-5	9388, 335, 336, 348, 338, 116519	76	59	12924	17.29348795718109	0.029699006414339313	0.0010767361796637641	0.0010018397961867782
GOTERM_CC_DIRECT	GO:0034362~low-density lipoprotein particle	4	4.651162790697675	2.9054330113480337E-5	344, 335, 348, 338	85	15	20521	64.37960784313725	0.004001528267084331	3.3412479630502386E-4	2.8085852443030993E-4
REACTOME_PATHWAY	R-HSA-8964058~HDL remodeling	4	4.651162790697675	2.958424915351739E-5	9388, 344, 335, 348	72	10	11044	61.355555555555554	0.012640840148549382	8.480818090674985E-4	7.573567783300452E-4
GAD_DISEASE	obesity	10	11.627906976744185	2.9688880996319843E-5	341, 335, 2244, 348, 338, 2243, 635, 5105, 2194, 116519	76	276	12924	6.16132723112128	0.03891711318131086	0.0013687597893820562	0.0012735506192904098
GAD_DISEASE	atherosclerosis, coronary	8	9.30232558139535	3.1240690466760473E-5	341, 344, 335, 2244, 348, 338, 635, 116519	76	155	12924	8.77691001697793	0.04090913189536782	0.0013922934384686253	0.0012954472980216676
GAD_DISEASE	HDL cholesterol	5	5.813953488372093	3.3257699121753914E-5	9388, 335, 348, 338, 116519	76	32	12924	26.570723684210524	0.04349215002126805	0.0014343723782511285	0.0013345992808858668
GOTERM_CC_DIRECT	GO:0031091~platelet alpha granule	4	4.651162790697675	3.565350242358251E-5	7057, 2244, 2266, 2243	85	16	20521	60.35588235294117	0.00490818634197232	3.7847564111187585E-4	3.181389447027362E-4
SMART	SM01212:Fib_alpha	3	3.488372093023256	3.881961432242738E-5	2244, 2266, 2243	40	3	10690	267.25	0.002365240836590954	0.0023679964736680703	0.002329176859345643
GOTERM_MF_DIRECT	GO:0005102~receptor binding	10	11.627906976744185	4.355634141251886E-5	2335, 335, 336, 2267, 2244, 2266, 348, 2243, 4018, 727	84	380	18883	5.915726817042606	0.011088727996969805	0.002787605850401207	0.002613380484751132
REACTOME_PATHWAY	R-HSA-76002~Platelet activation, signaling and aggregation	10	11.627906976744185	4.402376407891054E-5	7057, 6694, 3959, 2335, 335, 2244, 2266, 2243, 7018, 83706	72	263	11044	5.832277144064217	0.018752576141282673	0.001183138659620721	0.001056570337893853
UP_SEQ_FEATURE	SITE:Cleavage; by plasmin; to break down fibrin clots	3	3.488372093023256	4.8168314998713755E-5	2244, 2266, 2243	84	3	20562	244.78571428571428	0.026708103149119755	0.009023531009759044	0.0089914187997599
UP_SEQ_FEATURE	SITE:Cleavage; by hementin; to prevent blood coagulation	3	3.488372093023256	4.8168314998713755E-5	2244, 2266, 2243	84	3	20562	244.78571428571428	0.026708103149119755	0.009023531009759044	0.0089914187997599
INTERPRO	IPR037579:Fibrinogen	3	3.488372093023256	5.032821840293747E-5	2244, 2266, 2243	86	3	20603	239.56976744186048	0.018202557226358662	0.003673959943414435	0.0036035004376503226
INTERPRO	IPR018202:Ser_caboxypep_ser_AS	3	3.488372093023256	5.032821840293747E-5	5476, 59342, 54504	86	3	20603	239.56976744186048	0.018202557226358662	0.003673959943414435	0.0036035004376503226
INTERPRO	IPR012290:Fibrinogen_a/b/g_coil_dom	3	3.488372093023256	5.032821840293747E-5	2244, 2266, 2243	86	3	20603	239.56976744186048	0.018202557226358662	0.003673959943414435	0.0036035004376503226
INTERPRO	IPR001563:Peptidase_S10	3	3.488372093023256	5.032821840293747E-5	5476, 59342, 54504	86	3	20603	239.56976744186048	0.018202557226358662	0.003673959943414435	0.0036035004376503226
GAD_DISEASE	Coronary Disease	9	10.465116279069768	5.2234199603916866E-5	341, 344, 335, 336, 2244, 348, 338, 4018, 116519	76	229	12924	6.683291197425879	0.06745600492971504	0.0021687823500168755	0.0020179246398062773
GAD_DISEASE	Hypercholesterolemia	5	5.813953488372093	5.353015523601862E-5	335, 348, 338, 116519, 32	76	36	12924	23.61842105263158	0.0690705033433674	0.0021687823500168755	0.0020179246398062773
GOTERM_BP_DIRECT	GO:0034370~triglyceride-rich lipoprotein particle remodeling	3	3.488372093023256	5.62515137827289E-5	344, 336, 116519	85	3	19256	226.54117647058823	0.044381255634259986	0.004126815602060202	0.003968288608672511
INTERPRO	IPR020837:Fibrinogen_CS	4	4.651162790697675	6.260675372819145E-5	2267, 2244, 2266, 2243	86	19	20603	50.43574051407589	0.02259304706695564	0.00380857751846498	0.0037355363057820896
GOTERM_BP_DIRECT	GO:0006869~lipid transport	6	6.976744186046512	6.27067037663595E-5	344, 335, 336, 348, 4018, 116519	85	96	19256	14.158823529411764	0.049346747624963494	0.004217025828287676	0.004055033510224581
GAD_DISEASE	hyperlipidemia	4	4.651162790697675	6.525924822435365E-5	335, 348, 338, 116519	76	14	12924	48.58646616541353	0.08355613416688012	0.002566223966940024	0.0023877207291498805
GOTERM_CC_DIRECT	GO:0071682~endocytic vesicle lumen	4	4.651162790697675	7.172654490031932E-5	1514, 335, 348, 338	85	20	20521	48.28470588235294	0.009849788125776415	7.07018799731719E-4	5.94305657745503E-4
UP_KW_MOLECULAR_FUNCTION	KW-0503~Monooxygenase	6	6.976744186046512	7.37591563799309E-5	1558, 2328, 5053, 2330, 8529, 2329	57	93	11872	13.437464629315224	0.0025783360523051746	0.001978176948959813	0.0017520995833644058
SMART	SM00186:FBG	4	4.651162790697675	8.617880172244124E-5	2267, 2244, 2266, 2243	40	24	10690	44.541666666666664	0.00524333889291273	0.002628453452534458	0.0025853640516732375
GAD_DISEASE	plasma HDL-C levels	5	5.813953488372093	9.003262310735852E-5	9388, 344, 335, 336, 116519	76	41	12924	20.738125802310655	0.11341567452819401	0.0032386407251993703	0.0030133650427434677
GOTERM_CC_DIRECT	GO:0034363~intermediate-density lipoprotein particle	3	3.488372093023256	9.88134167445405E-5	344, 348, 338	85	4	20521	181.06764705882352	0.01354436364167344	9.090834340497726E-4	7.641570894911132E-4
GAD_DISEASE	triglycerides	5	5.813953488372093	9.907427003702184E-5	9388, 335, 348, 338, 116519	76	42	12924	20.24436090225564	0.12406979096912929	0.0032386407251993703	0.0030133650427434677
GAD_DISEASE	Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes	8	9.30232558139535	9.931401772581262E-5	7057, 3248, 2335, 335, 2244, 348, 338, 4018	76	186	12924	7.31409168081494	0.12435054681807478	0.0032386407251993703	0.0030133650427434677
GAD_DISEASE	myocardial infarct; thromboembolism, venous; thrombosis, deep vein	3	3.488372093023256	9.931508581389243E-5	2244, 2266, 2243	76	3	12924	170.05263157894737	0.12435179739834579	0.0032386407251993703	0.0030133650427434677
GAD_DISEASE	Coronary Disease|Diabetes Complications|Hypercholesterolemia|Hypertension|Myocardial Infarction	3	3.488372093023256	9.931508581389243E-5	341, 348, 338	76	3	12924	170.05263157894737	0.12435179739834579	0.0032386407251993703	0.0030133650427434677
GAD_DISEASE	Brain Ischemia|Cardiovascular Diseases|Carotid Artery Diseases|Myocardial Infarction|Stroke	3	3.488372093023256	9.931508581389243E-5	2244, 2266, 2243	76	3	12924	170.05263157894737	0.12435179739834579	0.0032386407251993703	0.0030133650427434677
GAD_DISEASE	lipids; left ventricular mass; aortic gradient; aortic valve stenosis	3	3.488372093023256	9.931508581389243E-5	335, 348, 338	76	3	12924	170.05263157894737	0.12435179739834579	0.0032386407251993703	0.0030133650427434677
INTERPRO	IPR000074:ApoA_E	3	3.488372093023256	1.0038615945873331E-4	335, 348, 116519	86	4	20603	179.67732558139534	0.03597956594866736	0.0052344211717768084	0.005134035012318076
GAD_DISEASE	Chorioamnionitis|Fetal Membranes, Premature Rupture|Infection of amniotic sac and membranes|Obstetric Labor, Premature|Pre-Eclampsia|Premature Birth	8	9.30232558139535	1.0270198410677359E-4	7057, 3248, 2335, 335, 2244, 348, 338, 4018	76	187	12924	7.274978891077962	0.12830841483232736	0.003269346494065626	0.003041934957829199
GAD_DISEASE	patent ductus arteriosus	7	8.13953488372093	1.0526853301351528E-4	2328, 344, 3248, 335, 348, 338, 116519	76	130	12924	9.156680161943319	0.1312947872643937	0.0032731169450946496	0.0030454431411351865
REACTOME_PATHWAY	R-HSA-354194~GRB2:SOS provides linkage to MAPK signaling for Integrins 	4	4.651162790697675	1.0961216786945034E-4	2335, 2244, 2266, 2243	72	15	11044	40.9037037037037	0.046042173525223995	0.002618512899103536	0.002338392914548274
REACTOME_PATHWAY	R-HSA-372708~p130Cas linkage to MAPK signaling for integrins	4	4.651162790697675	1.0961216786945034E-4	2335, 2244, 2266, 2243	72	15	11044	40.9037037037037	0.046042173525223995	0.002618512899103536	0.002338392914548274
GOTERM_BP_DIRECT	GO:0032375~negative regulation of cholesterol transport	3	3.488372093023256	1.1218370608507755E-4	341, 344, 336	85	4	19256	169.90588235294118	0.08655976483121941	0.006964019293127507	0.00669650430169386
UP_KW_MOLECULAR_FUNCTION	KW-0560~Oxidoreductase	12	13.953488372093023	1.130386827977036E-4	10437, 1558, 2328, 5053, 5264, 1610, 3248, 2330, 2671, 2194, 8529, 2329	57	613	11872	4.077273117540997	0.003948760585271827	0.001978176948959813	0.0017520995833644058
GAD_DISEASE	Angina Pectoris|Myocardial Infarction|Obesity|Recurrence	4	4.651162790697675	1.2039474828113202E-4	335, 2244, 348, 338	76	17	12924	40.012383900928796	0.14868874827243683	0.0036583586011789434	0.003403887883221096
REACTOME_PATHWAY	R-HSA-1474244~Extracellular matrix organization	10	11.627906976744185	1.2124898850647657E-4	1514, 7057, 2335, 2244, 2266, 2243, 2331, 4148, 1291, 4060	72	300	11044	5.112962962962963	0.05080424450536203	0.0027440560556728907	0.0024505058729730003
UP_KW_BIOLOGICAL_PROCESS	KW-0399~Innate immunity	10	11.627906976744185	1.2545200413065298E-4	3437, 730, 3434, 3433, 2244, 2243, 727, 5648, 3669, 383	54	424	11447	4.9995632424877705	0.0071257037326449835	0.0017876910588618049	0.0014426980475025092
WIKIPATHWAYS	WP5323:Fatty acids and lipoproteins transport in hepatocytes	5	5.813953488372093	1.2557388881264618E-4	341, 344, 348, 338, 4018	64	35	8414	18.78125	0.025660454933593035	0.00371339928345968	0.003390494997941447
OMIM_DISEASE	616004~Dysfibrinogenemia, congenital	3	3.488372093023256	1.2797813455220147E-4	2244, 2266, 2243	41	3	6035	147.1951219512195	0.008919030069331702	0.004479234709327051	0.004479234709327051
OMIM_DISEASE	202400~Afibrinogenemia, congenital	3	3.488372093023256	1.2797813455220147E-4	2244, 2266, 2243	41	3	6035	147.1951219512195	0.008919030069331702	0.004479234709327051	0.004479234709327051
GAD_DISEASE	coronary heart disease	5	5.813953488372093	1.301587589831688E-4	344, 335, 2244, 348, 338	76	45	12924	18.894736842105264	0.15973132492289854	0.00386716135023326	0.0035981665816680443
GOTERM_MF_DIRECT	GO:0008201~heparin binding	7	8.13953488372093	1.3761363949924438E-4	9388, 7057, 2335, 348, 338, 4018, 116519	84	179	18883	8.79096834264432	0.03461811090811939	0.006630703742135797	0.00621628475825231
GAD_DISEASE	Myocardial Infarction	12	13.953488372093023	1.5299829206924975E-4	1558, 7057, 2335, 3434, 335, 2244, 2266, 348, 338, 2243, 4018, 8529	76	507	12924	4.0249143568981625	0.18500586872768265	0.00444692861949102	0.004137605985524928
GOTERM_BP_DIRECT	GO:0006805~xenobiotic metabolic process	6	6.976744186046512	1.5370816024102784E-4	1558, 11309, 2330, 6822, 8529, 2329	85	116	19256	11.717647058823529	0.11666611086668222	0.008860177522464962	0.008519823739074115
INTERPRO	IPR014716:Fibrinogen_a/b/g_C_1	4	4.651162790697675	1.6451645849819554E-4	2267, 2244, 2266, 2243	86	26	20603	36.856887298747765	0.058285799915241854	0.007506063418980171	0.00736211151779425
WIKIPATHWAYS	WP5112:Familial hyperlipidemia type 5	4	4.651162790697675	1.7072789389370617E-4	344, 335, 336, 116519	64	15	8414	35.05833333333333	0.034726396801670556	0.0044175842544996475	0.004033446493238809
GOTERM_BP_DIRECT	GO:0034382~chylomicron remnant clearance	3	3.488372093023256	1.8644232000866195E-4	341, 344, 348	85	5	19256	135.92470588235295	0.13969902493009156	0.009403684515436887	0.009042452520420104
GOTERM_BP_DIRECT	GO:0055090~acylglycerol homeostasis	3	3.488372093023256	1.8644232000866195E-4	335, 348, 116519	85	5	19256	135.92470588235295	0.13969902493009156	0.009403684515436887	0.009042452520420104
GOTERM_MF_DIRECT	GO:0055102~lipase inhibitor activity	3	3.488372093023256	1.8925289922568225E-4	341, 344, 336	84	5	18883	134.8785714285714	0.04729819657847956	0.006630703742135797	0.00621628475825231
GOTERM_MF_DIRECT	GO:0004185~serine-type carboxypeptidase activity	3	3.488372093023256	1.8925289922568225E-4	5476, 59342, 54504	84	5	18883	134.8785714285714	0.04729819657847956	0.006630703742135797	0.00621628475825231
REACTOME_PATHWAY	R-HSA-5668914~Diseases of metabolism	9	10.465116279069768	1.9140288201625213E-4	2328, 5053, 7057, 2588, 5476, 2331, 2719, 4758, 4060	72	250	11044	5.522	0.07901461991528647	0.004115161963349421	0.003674935334712041
GAD_DISEASE	Alzheimer's disease; triglycerides; atherosclerosis, coronary	3	3.488372093023256	1.978824034503539E-4	335, 348, 338	76	4	12924	127.53947368421052	0.23248323308741958	0.005629122838577089	0.0052375682955795805
GOTERM_MF_DIRECT	GO:0008289~lipid binding	7	8.13953488372093	2.0720949194174366E-4	83758, 344, 335, 336, 348, 116519, 83706	84	193	18883	8.153281519861832	0.05166847360561344	0.006630703742135797	0.00621628475825231
GOTERM_CC_DIRECT	GO:0005764~lysosome	8	9.30232558139535	2.079645579324971E-4	10404, 10437, 1514, 1522, 2588, 5476, 5641, 4758	85	295	20521	6.547078763708873	0.028294101248580006	0.0017936943121677875	0.001507743045010604
REACTOME_PATHWAY	R-HSA-9024446~NR1H2 and NR1H3-mediated signaling	5	5.813953488372093	2.270485959786232E-4	341, 344, 348, 5105, 2194	72	47	11044	16.317966903073287	0.09302644098716939	0.0044535573860378696	0.0039771303168338185
REACTOME_PATHWAY	R-HSA-3000480~Scavenging by Class A Receptors	4	4.651162790697675	2.2916820378931173E-4	335, 348, 338, 5648	72	19	11044	32.292397660818715	0.09385289696561605	0.0044535573860378696	0.0039771303168338185
GAD_DISEASE	Coronary Artery Disease|	5	5.813953488372093	2.2935550128819549E-4	335, 2244, 348, 4018, 116519	76	52	12924	16.351214574898787	0.2641165114154026	0.006388506358798279	0.0059441300750524
REACTOME_PATHWAY	R-HSA-196854~Metabolism of vitamins and cofactors	8	9.30232558139535	2.3821353460202558E-4	344, 335, 336, 348, 338, 2719, 2194, 32	72	194	11044	6.3253150057273775	0.09737132443934138	0.0044535573860378696	0.0039771303168338185
INTERPRO	IPR020946:Flavin_mOase-like	3	3.488372093023256	2.4962005629408944E-4	2328, 2330, 2329	86	6	20603	119.78488372093024	0.08709430406636354	0.009111132054734265	0.008936398015328402
INTERPRO	IPR000960:Flavin_mOase	3	3.488372093023256	2.4962005629408944E-4	2328, 2330, 2329	86	6	20603	119.78488372093024	0.08709430406636354	0.009111132054734265	0.008936398015328402
GOTERM_CC_DIRECT	GO:0031012~extracellular matrix	7	8.13953488372093	2.6042235596623854E-4	7057, 2335, 348, 2331, 4148, 1291, 4060	85	216	20521	7.823910675381263	0.03530468717337143	0.0021140167719612304	0.0017769996054166864
GAD_DISEASE	cerebrovascular disease; sickle cell anemia	4	4.651162790697675	2.670283536385718E-4	335, 2244, 348, 2243	76	22	12924	30.918660287081337	0.3002726949974962	0.00714033817629541	0.006643665438527666
GAD_DISEASE	lipid profiles	4	4.651162790697675	2.670283536385718E-4	9388, 348, 338, 116519	76	22	12924	30.918660287081337	0.3002726949974962	0.00714033817629541	0.006643665438527666
GOTERM_BP_DIRECT	GO:0042158~lipoprotein biosynthetic process	3	3.488372093023256	2.788702049415573E-4	335, 348, 338	85	6	19256	113.27058823529411	0.2015473732183295	0.013238132669872749	0.012729604649096967
GOTERM_MF_DIRECT	GO:0004499~N,N-dimethylaniline monooxygenase activity	3	3.488372093023256	2.830682261152984E-4	2328, 2330, 2329	84	6	18883	112.39880952380952	0.06991167493550698	0.007246546588551639	0.0067936374267671615
GOTERM_MF_DIRECT	GO:0047822~hypotaurine dehydrogenase activity	3	3.488372093023256	2.830682261152984E-4	2328, 2330, 2329	84	6	18883	112.39880952380952	0.06991167493550698	0.007246546588551639	0.0067936374267671615
UP_KW_BIOLOGICAL_PROCESS	KW-0153~Cholesterol metabolism	5	5.813953488372093	2.8340305174425054E-4	335, 3158, 3422, 348, 338	54	69	11447	15.360976918947932	0.016026451035427214	0.0032307947898844564	0.002607308076047105
GOTERM_CC_DIRECT	GO:0005769~early endosome	8	9.30232558139535	2.9231210661062536E-4	9388, 344, 335, 336, 348, 338, 7018, 116519	85	312	20521	6.190346907993967	0.0395419449713621	0.0022410594840147945	0.0018837891314906969
WIKIPATHWAYS	WP5108:Familial hyperlipidemia type 1	4	4.651162790697675	3.013132741034883E-4	344, 335, 336, 116519	64	18	8414	29.21527777777778	0.06047537184183227	0.006930205304380231	0.006327578756173255
UP_KW_LIGAND	KW-0274~FAD	6	6.976744186046512	3.019585761721781E-4	2328, 1610, 2330, 2671, 26007, 2329	37	116	6921	9.675209692451071	0.007821361271210026	0.00641602151652805	0.00641602151652805
KEGG_PATHWAY	hsa04610:Complement and coagulation cascades	6	6.976744186046512	3.051516984407078E-4	730, 2244, 2266, 2243, 727, 5648	61	86	8662	9.906976744186046	0.03743124666671005	0.012714654101696157	0.012206067937628313
REACTOME_PATHWAY	R-HSA-5686938~Regulation of TLR by endogenous ligand	4	4.651162790697675	3.116569171477388E-4	2244, 2266, 338, 2243	72	21	11044	29.216931216931215	0.12543911269572294	0.005583853098896987	0.00498651067436382
GAD_DISEASE	fibrinogen myocardial infarct	3	3.488372093023256	3.2856293282680936E-4	2244, 2266, 2243	76	5	12924	102.03157894736842	0.3555517946951917	0.008288464928102719	0.007711929970500959
GAD_DISEASE	myocardial infarction | metabolic syndrome	3	3.488372093023256	3.2856293282680936E-4	348, 338, 4018	76	5	12924	102.03157894736842	0.3555517946951917	0.008288464928102719	0.007711929970500959
GAD_DISEASE	fibrinogen heart disease, ischemic tissue plasminogen activator level	3	3.488372093023256	3.2856293282680936E-4	2244, 2266, 2243	76	5	12924	102.03157894736842	0.3555517946951917	0.008288464928102719	0.007711929970500959
UP_SEQ_FEATURE	DOMAIN:Fibrinogen C-terminal	4	4.651162790697675	3.467212762615403E-4	2267, 2244, 2266, 2243	84	34	20562	28.79831932773109	0.17707576794940016	0.04871433931474641	0.048540978676615644
GAD_DISEASE	Macular Degeneration	8	9.30232558139535	3.476916668604579E-4	5176, 730, 2244, 2266, 348, 2243, 727, 5648	76	228	12924	5.9667590027700825	0.3718300901093573	0.008608588122082077	0.008009785806933511
INTERPRO	IPR002181:Fibrinogen_a/b/g_C_dom	4	4.651162790697675	3.6972987257244633E-4	2267, 2244, 2266, 2243	86	34	20603	28.18467852257182	0.1262634311716604	0.011245950290745243	0.011030274531744648
INTERPRO	IPR036056:Fibrinogen-like_C	4	4.651162790697675	3.6972987257244633E-4	2267, 2244, 2266, 2243	86	34	20603	28.18467852257182	0.1262634311716604	0.011245950290745243	0.011030274531744648
GAD_DISEASE	Coronary Artery Disease	11	12.790697674418606	3.846322539217988E-4	341, 1558, 9388, 344, 2335, 335, 348, 338, 635, 4018, 116519	76	473	12924	3.9547123623011013	0.4021122478398198	0.009350060427153544	0.00869968225234032
GOTERM_BP_DIRECT	GO:0072378~blood coagulation, fibrin clot formation	3	3.488372093023256	3.893112043037725E-4	2244, 2266, 2243	85	7	19256	97.08907563025211	0.26965285261124994	0.017454118992952468	0.016783638585540415
GAD_DISEASE	Kidney Failure, Chronic	7	8.13953488372093	4.509455301958309E-4	1558, 9388, 335, 2244, 348, 5105, 116519	76	170	12924	7.002167182662538	0.4528597743982655	0.010766324533425463	0.010017432849350244
UP_KW_BIOLOGICAL_PROCESS	KW-1207~Sterol metabolism	5	5.813953488372093	4.534665977961565E-4	335, 3158, 3422, 348, 338	54	78	11447	13.58855650522317	0.02552211926461334	0.004307932679063487	0.0034765772497705335
GOTERM_CC_DIRECT	GO:0034366~spherical high-density lipoprotein particle	3	3.488372093023256	4.562398042713644E-4	344, 335, 336	85	8	20521	90.53382352941176	0.06103348439084988	0.0033137417362867523	0.002785464068183067
GAD_DISEASE	Hepatitis C|Remission, Spontaneous	6	6.976744186046512	4.760254897883606E-4	341, 344, 335, 336, 348, 116519	76	112	12924	9.109962406015038	0.47091046609950116	0.01094090645881226	0.010179871080600188
GAD_DISEASE	Brain Ischemia|Hemorrhage	3	3.488372093023256	4.909905665884335E-4	2244, 348, 2243	76	6	12924	85.02631578947368	0.4813964687769293	0.01094090645881226	0.010179871080600188
GAD_DISEASE	Metabolic Syndrome X|Obesity, Abdominal	3	3.488372093023256	4.909905665884335E-4	335, 348, 116519	76	6	12924	85.02631578947368	0.4813964687769293	0.01094090645881226	0.010179871080600188
GAD_DISEASE	Ischemia|Stroke	3	3.488372093023256	4.909905665884335E-4	2244, 2266, 2243	76	6	12924	85.02631578947368	0.4813964687769293	0.01094090645881226	0.010179871080600188
UP_KW_LIGAND	KW-0285~Flavoprotein	6	6.976744186046512	4.935401166560039E-4	2328, 1610, 2330, 2671, 26007, 2329	37	129	6921	8.700188560653677	0.01275319061304514	0.00641602151652805	0.00641602151652805
GAD_DISEASE	Brain Ischemia|Hypertension|Osteoporosis|Stroke	5	5.813953488372093	5.107452868457242E-4	2244, 348, 338, 4018, 727	76	64	12924	13.285361842105262	0.4949212358845656	0.011194531942831692	0.010415854702230835
GOTERM_BP_DIRECT	GO:0070328~triglyceride homeostasis	4	4.651162790697675	5.153119498414891E-4	344, 335, 348, 116519	85	36	19256	25.17124183006536	0.3402959333112803	0.020885569556068424	0.020083273823431343
GOTERM_BP_DIRECT	GO:0034372~very-low-density lipoprotein particle remodeling	3	3.488372093023256	5.176101500884367E-4	344, 348, 116519	85	8	19256	84.95294117647059	0.3415189490324789	0.020885569556068424	0.020083273823431343
REACTOME_PATHWAY	R-HSA-2187338~Visual phototransduction	6	6.976744186046512	5.347700561835575E-4	344, 335, 336, 348, 338, 2719	72	104	11044	8.849358974358974	0.2054764336447853	0.00919804496635719	0.008214068062979444
GAD_DISEASE	Amyotrophic Lateral Sclerosis|	5	5.813953488372093	5.41862300606828E-4	3248, 2244, 348, 338, 4018	76	65	12924	13.080971659919028	0.5155137599224879	0.01168499832115047	0.010872204870240227
WIKIPATHWAYS	WP688:Catalytic cycle of mammalian flavin containing monooxygenases FMOs 	3	3.488372093023256	5.438363568802412E-4	2328, 2330, 2329	64	5	8414	78.88125	0.10649625046009858	0.010474872404417737	0.00956401393446837
WIKIPATHWAYS	WP5111:Familial hyperlipidemia type 4	4	4.651162790697675	5.566357316357252E-4	344, 335, 336, 116519	64	22	8414	23.903409090909093	0.1088617289068724	0.010474872404417737	0.00956401393446837
GOTERM_BP_DIRECT	GO:0006641~triglyceride metabolic process	4	4.651162790697675	5.590212656402698E-4	341, 336, 348, 116519	85	37	19256	24.49093799682035	0.36317240024139574	0.02148238863674751	0.020657166768421397
GOTERM_BP_DIRECT	GO:1905920~positive regulation of CoA-transferase activity	3	3.488372093023256	6.636128573581655E-4	335, 336, 348	85	9	19256	75.51372549019608	0.4147483472963497	0.024342526176729072	0.023407435332269837
REACTOME_PATHWAY	R-HSA-354192~Integrin signaling	4	4.651162790697675	6.667245933466128E-4	2335, 2244, 2266, 2243	72	27	11044	22.724279835390945	0.24932853761777451	0.011026599043809366	0.009847009378657666
GAD_DISEASE	Acute Coronary Syndrome|Coronary Artery Disease	3	3.488372093023256	6.848022670633554E-4	2244, 2266, 2243	76	7	12924	72.8796992481203	0.5998413838517753	0.014533025889900096	0.013522127305187525
PIR_SUPERFAMILY	PIRSF000332:FMO	3	3.488372093023256	7.138363903332575E-4	2328, 2330, 2329	15	6	1940	64.66666666666667	0.010654206953551904	0.010707545854998862	0.010707545854998862
UP_KW_MOLECULAR_FUNCTION	KW-0121~Carboxypeptidase	4	4.651162790697675	7.460453757382402E-4	10404, 5476, 59342, 54504	57	38	11872	21.924284395198523	0.02578312242632297	0.007691222775930835	0.006812225887253026
GOTERM_BP_DIRECT	GO:0034380~high-density lipoprotein particle assembly	3	3.488372093023256	8.271661186341141E-4	335, 336, 348	85	10	19256	67.96235294117648	0.4871640580886949	0.029022741640770875	0.027907865567829242
GAD_DISEASE	cholesterol, HDL triglycerides	3	3.488372093023256	9.096380437541797E-4	335, 348, 116519	76	8	12924	63.76973684210526	0.7038056773819326	0.01900290725780216	0.017681089475471867
REACTOME_PATHWAY	R-HSA-1989781~PPARA activates gene expression	6	6.976744186046512	9.135350126827051E-4	335, 336, 3158, 84498, 6822, 116519	72	117	11044	7.866096866096866	0.3249709771648539	0.014548890942724562	0.012992497958154027
GOTERM_BP_DIRECT	GO:0016042~lipid catabolic process	5	5.813953488372093	9.257239746558236E-4	9388, 344, 63874, 6822, 4758	85	99	19256	11.441473559120617	0.5264061809191148	0.030089429092585496	0.02893357741740563
GOTERM_BP_DIRECT	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	4	4.651162790697675	9.321384477256969E-4	335, 2244, 2266, 2243	85	44	19256	20.59465240641711	0.5288536631427587	0.030089429092585496	0.02893357741740563
GAD_DISEASE	diabetes, type 2	10	11.627906976744185	9.547728668360236E-4	344, 335, 336, 2244, 348, 338, 5105, 4018, 727, 116519	76	439	12924	3.873636254645726	0.721166684133153	0.01963894343015021	0.0182728837899079
REACTOME_PATHWAY	R-HSA-400206~Regulation of lipid metabolism by PPARalpha	6	6.976744186046512	9.859840882879749E-4	335, 336, 3158, 84498, 6822, 116519	72	119	11044	7.733893557422968	0.34569541579027563	0.015141898498708187	0.013522067496520797
GOTERM_BP_DIRECT	GO:0031639~plasminogen activation	3	3.488372093023256	0.0010081176986417933	2244, 2266, 2243	85	11	19256	61.78395721925133	0.5569006803407051	0.030131517881626935	0.028974049412815985
GOTERM_BP_DIRECT	GO:0090277~positive regulation of peptide hormone secretion	3	3.488372093023256	0.0010081176986417933	2244, 2266, 2243	85	11	19256	61.78395721925133	0.5569006803407051	0.030131517881626935	0.028974049412815985
UP_KW_MOLECULAR_FUNCTION	KW-0358~Heparin-binding	5	5.813953488372093	0.0010689556101957244	9388, 7057, 2335, 348, 338	57	96	11872	10.847953216374268	0.03674148656571119	0.007691222775930835	0.006812225887253026
UP_KW_MOLECULAR_FUNCTION	KW-0378~Hydrolase	19	22.093023255813954	0.0010987461108472622	9388, 5476, 5641, 63874, 59342, 2194, 383, 10404, 1514, 57733, 1522, 2588, 54504, 5424, 51733, 4018, 5648, 3669, 4758	57	1801	11872	2.197297797519896	0.03774641012935498	0.007691222775930835	0.006812225887253026
WIKIPATHWAYS	WP4927:COVID 19 thrombosis and anticoagulation	3	3.488372093023256	0.0011310607838175741	2244, 2266, 2243	64	7	8414	56.34375	0.20884556460509696	0.019510798520853155	0.017814207345126794
GAD_DISEASE	body mass; triglycerides; cholesterol, total; blood pressure; leptin; apoA1; apoA2; fasting blood sugar; fasting blood sugar	3	3.488372093023256	0.001165140931003216	335, 336, 348	76	9	12924	56.68421052631579	0.7895909224368418	0.023602930678049996	0.021961141184363646
UP_KW_BIOLOGICAL_PROCESS	KW-0442~Lipid degradation	5	5.813953488372093	0.0012000935404960194	9388, 344, 63874, 6822, 4758	54	101	11447	10.494132746607994	0.06615649756882547	0.00977219025832473	0.007886328980402414
GOTERM_BP_DIRECT	GO:0009615~response to virus	5	5.813953488372093	0.0012793707002784899	3437, 3434, 3433, 338, 3669	85	108	19256	10.488017429193901	0.6441027322410788	0.03687329125445505	0.035456845122003866
SMART	SM00028:TPR	5	5.813953488372093	0.0013071693818291128	3437, 143941, 3434, 3433, 23523	40	132	10690	10.12310606060606	0.07668931056881556	0.026579110763858625	0.026143387636582256
REACTOME_PATHWAY	R-HSA-3000178~ECM proteoglycans	5	5.813953488372093	0.0014197358148665986	2335, 2331, 4148, 1291, 4060	72	76	11044	10.091374269005849	0.45714887923333525	0.02105125518595301	0.018799260445130132
UP_KW_CELLULAR_COMPONENT	KW-0272~Extracellular matrix	7	8.13953488372093	0.001427533667875601	7057, 3959, 2335, 348, 2331, 1291, 4060	80	278	17910	5.637140287769784	0.041951242242889486	0.008565202007253607	0.006566654872227765
UP_KW_PTM	KW-0558~Oxidation	4	4.651162790697675	0.0014328954289308954	2335, 335, 336, 348	75	43	14237	17.65829457364341	0.03244231113516316	0.017194745147170745	0.015045402003774402
GAD_DISEASE	Hypertension	9	10.465116279069768	0.0014431666046804475	10404, 2328, 2244, 2266, 348, 338, 2243, 2331, 8529	76	375	12924	4.081263157894736	0.8549834487269751	0.027322950184362618	0.02542240091948175
GAD_DISEASE	gallstones	3	3.488372093023256	0.0014509569656617398	341, 335, 348	76	10	12924	51.01578947368421	0.8564882266675098	0.027322950184362618	0.02542240091948175
GAD_DISEASE	hypertriglyceridemia	3	3.488372093023256	0.0014509569656617398	336, 348, 116519	76	10	12924	51.01578947368421	0.8564882266675098	0.027322950184362618	0.02542240091948175
GAD_DISEASE	thrombophilia and vascular disease	3	3.488372093023256	0.0014509569656617398	2244, 348, 338	76	10	12924	51.01578947368421	0.8564882266675098	0.027322950184362618	0.02542240091948175
GAD_DISEASE	Anemia, Sickle Cell|beta Thalassemia|beta-Thalassemia|Blood Coagulation Disorders, Inherited|Sickle cell anemia|Vascular Diseases	3	3.488372093023256	0.0014509569656617398	2244, 348, 338	76	10	12924	51.01578947368421	0.8564882266675098	0.027322950184362618	0.02542240091948175
REACTOME_PATHWAY	R-HSA-6802948~Signaling by high-kinase activity BRAF mutants	4	4.651162790697675	0.0015615131707909459	2335, 2244, 2266, 2243	72	36	11044	17.04320987654321	0.48930127879971663	0.02238168878133689	0.01998736858612411
GAD_DISEASE	Peripheral Vascular Diseases	4	4.651162790697675	0.0015894819527364692	2244, 2266, 2243, 4018	76	40	12924	17.005263157894735	0.8807851672631242	0.02951579681678693	0.027462715961168997
GOTERM_BP_DIRECT	GO:0051592~response to calcium ion	4	4.651162790697675	0.0016028889064851628	7057, 2244, 2266, 2243	85	53	19256	17.097447280799113	0.7259841014010473	0.044488685200110956	0.04277970224942516
WIKIPATHWAYS	WP3942:PPAR signaling pathway	5	5.813953488372093	0.0016241330586113422	335, 336, 3158, 5105, 116519	64	68	8414	9.666819852941176	0.285711868300343	0.025350041854529715	0.023145690388918436
GOTERM_BP_DIRECT	GO:0034116~positive regulation of heterotypic cell-cell adhesion	3	3.488372093023256	0.0016538544684056118	2244, 2266, 2243	85	14	19256	48.544537815126056	0.7370431796722245	0.044488685200110956	0.04277970224942516
GOTERM_MF_DIRECT	GO:0043394~proteoglycan binding	3	3.488372093023256	0.001678472396212789	1514, 7057, 2335	84	14	18883	48.170918367346935	0.3495233960691231	0.039062630311861274	0.03662121591736994
REACTOME_PATHWAY	R-HSA-8964043~Plasma lipoprotein clearance	4	4.651162790697675	0.0016915076014885721	341, 335, 348, 338	72	37	11044	16.58258258258258	0.5171089020235492	0.023462847375486647	0.020952868353922956
UP_KW_DISEASE	KW-0065~Atherosclerosis	3	3.488372093023256	0.0016937082826515295	335, 338, 4018	39	8	4749	45.66346153846154	0.03823805489213694	0.03895529050098518	0.03895529050098518
GAD_DISEASE	Atherosclerosis	4	4.651162790697675	0.0017078595314272838	9388, 335, 2244, 348	76	41	12924	16.590500641848525	0.8982625991258703	0.03127956429477094	0.02910379804240467
WIKIPATHWAYS	WP176:Folate metabolism	5	5.813953488372093	0.0017144955843643285	335, 2244, 2266, 338, 2243	64	69	8414	9.526721014492754	0.2989704031203321	0.025350041854529715	0.023145690388918436
KEGG_PATHWAY	hsa03320:PPAR signaling pathway	5	5.813953488372093	0.0017523674344080073	335, 336, 3158, 5105, 116519	61	75	8662	9.466666666666667	0.19686951254047536	0.053164820934077386	0.051038228096714294
GAD_DISEASE	Myocardial ischemia	3	3.488372093023256	0.0017667351651410878	335, 348, 338	76	11	12924	46.377990430622006	0.9059768265759448	0.03192060697018425	0.029700250613993423
UP_KW_CELLULAR_COMPONENT	KW-0492~Microsome	5	5.813953488372093	0.0018388717606364498	1558, 2328, 2330, 8529, 2329	80	118	17910	9.486228813559322	0.05372015726022039	0.00919435880318225	0.007049008415773058
REACTOME_PATHWAY	R-HSA-109582~Hemostasis	12	13.953488372093023	0.0019322077576889756	81027, 7057, 6694, 3959, 2335, 335, 2244, 2266, 338, 2243, 7018, 83706	72	622	11044	2.9592711682743835	0.5646709330129411	0.025687310570595045	0.02293936571885697
REACTOME_PATHWAY	R-HSA-76009~Platelet Aggregation (Plug Formation)	4	4.651162790697675	0.0019713517414642707	2335, 2244, 2266, 2243	72	39	11044	15.732193732193732	0.5719511213650743	0.025687310570595045	0.02293936571885697
GAD_DISEASE	Dyslipidemias	3	3.488372093023256	0.0021121275053654505	335, 348, 116519	76	12	12924	42.51315789473684	0.9408039767567058	0.0376521929956481	0.03503315488899494
REACTOME_PATHWAY	R-HSA-5674135~MAP2K and MAPK activation	4	4.651162790697675	0.0021214334055634286	2335, 2244, 2266, 2243	72	40	11044	15.338888888888889	0.5987559118295366	0.02682989307036101	0.02395971846283402
KEGG_PATHWAY	hsa04142:Lysosome	6	6.976744186046512	0.0021265928373630956	1514, 1522, 2588, 5476, 5641, 4758	61	132	8662	6.454545454545454	0.23364299653490406	0.053164820934077386	0.051038228096714294
UP_SEQ_FEATURE	CARBOHYD:O-linked (GalNAc...) threonine	5	5.813953488372093	0.002246554288997891	730, 2335, 348, 2243, 3698	84	136	20562	8.999474789915967	0.7174737597284051	0.19656768350805026	0.19586815438524582
REACTOME_PATHWAY	R-HSA-3781865~Diseases of glycosylation	6	6.976744186046512	0.0022947604270786366	7057, 5476, 2331, 2719, 4758, 4060	72	144	11044	6.391203703703703	0.6276350631836051	0.028192770961251824	0.025176800114234184
GAD_DISEASE	Lymphoma, Non-Hodgkin	7	8.13953488372093	0.002299005011636779	730, 56288, 336, 3158, 348, 338, 727	76	233	12924	5.108877343573526	0.9539168742269399	0.04005827419452121	0.03727187217500701
UP_KW_CELLULAR_COMPONENT	KW-0458~Lysosome	8	9.30232558139535	0.00238872602700807	10404, 10437, 1514, 1522, 2588, 5476, 5641, 4758	80	416	17910	4.305288461538462	0.06923412248612726	0.010237397258606014	0.007848671231597944
REACTOME_PATHWAY	R-HSA-2173782~Binding and Uptake of Ligands by Scavenger Receptors	4	4.651162790697675	0.002442473740055858	335, 348, 338, 5648	72	42	11044	14.608465608465607	0.6506036826742807	0.029173991895111637	0.026053053227262483
GOTERM_MF_DIRECT	GO:0005543~phospholipid binding	5	5.813953488372093	0.0024487730542796047	335, 336, 348, 338, 116519	84	128	18883	8.781156994047619	0.46615764976699425	0.052240491824631564	0.048975461085592094
GOTERM_BP_DIRECT	GO:0051258~protein polymerization	3	3.488372093023256	0.002450787836832694	2244, 2266, 2243	85	17	19256	39.97785467128028	0.8619602122089456	0.06379954142980594	0.061348753592973246
GAD_DISEASE	cholesterol, LDL	3	3.488372093023256	0.0024867888991363203	341, 348, 338	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	lipid metabolism	3	3.488372093023256	0.0024867888991363203	2244, 348, 338	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	Lipid Metabolism	3	3.488372093023256	0.0024867888991363203	9388, 348, 116519	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	Brain Ischemia|Stroke|Vascular Diseases	3	3.488372093023256	0.0024867888991363203	2244, 2266, 2243	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	fibrinogen	3	3.488372093023256	0.0024867888991363203	2244, 2266, 2243	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	Atherosclerosis|Brain Ischemia|Carotid Stenosis|Thrombosis	3	3.488372093023256	0.0024867888991363203	2244, 2266, 2243	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	Dyslipidemias|HIV Infections|[X]Human immunodeficiency virus disease	3	3.488372093023256	0.0024867888991363203	9388, 348, 116519	76	13	12924	39.24291497975709	0.9641702852267284	0.04005827419452121	0.03727187217500701
GAD_DISEASE	Alzheimer's disease	7	8.13953488372093	0.0025561903203055025	341, 335, 3158, 348, 5105, 7018, 116519	76	238	12924	5.001547987616099	0.9673529888021779	0.04068602926486258	0.037855961410238635
KEGG_PATHWAY	hsa00260:Glycine, serine and threonine metabolism	4	4.651162790697675	0.002601987531828241	1610, 27232, 635, 2628	61	40	8662	14.2	0.2779582549433779	0.05420807357975501	0.05203975063656482
REACTOME_PATHWAY	R-HSA-9656223~Signaling by RAF1 mutants	4	4.651162790697675	0.0026136468744973845	2335, 2244, 2266, 2243	72	43	11044	14.268733850129198	0.6754577066432119	0.030374815027942575	0.027125416210999884
GAD_DISEASE	metabolic syndrome	6	6.976744186046512	0.002682653457584752	2244, 348, 338, 5105, 116519, 32	76	165	12924	6.183732057416267	0.9724437867109651	0.04219656085636251	0.039261422367475665
INTERPRO	IPR019734:TPR_repeat	5	5.813953488372093	0.002701723421086495	3437, 143941, 3434, 3433, 23523	86	140	20603	8.556063122923588	0.6274796370042149	0.07585608066896699	0.07440130651915118
GOTERM_BP_DIRECT	GO:0034374~low-density lipoprotein particle remodeling	3	3.488372093023256	0.002749345595681382	336, 348, 338	85	18	19256	37.75686274509804	0.8915837739391388	0.06933505924108986	0.06667163069527351
UP_SEQ_FEATURE	REPEAT:TPR 3	5	5.813953488372093	0.0029034212026175714	3437, 143941, 3434, 3433, 23523	84	146	20562	8.38307240704501	0.8048713316074899	0.19656768350805026	0.19586815438524582
GOTERM_MF_DIRECT	GO:0005518~collagen binding	4	4.651162790697675	0.0029394383227596597	1514, 2335, 1291, 4060	84	65	18883	13.833699633699633	0.5293329526494855	0.05788432389434407	0.054266553650947555
GOTERM_BP_DIRECT	GO:0042730~fibrinolysis	3	3.488372093023256	0.00306411814659663	2244, 2266, 2243	85	19	19256	35.76965944272446	0.9159664781179874	0.0727277454206906	0.06993399063997015
GOTERM_BP_DIRECT	GO:0019433~triglyceride catabolic process	3	3.488372093023256	0.00306411814659663	9388, 338, 116519	85	19	19256	35.76965944272446	0.9159664781179874	0.0727277454206906	0.06993399063997015
GAD_DISEASE	Hyperlipidemias|Hypertension	3	3.488372093023256	0.0033225530524183078	335, 348, 338	76	15	12924	34.01052631578948	0.9883173404910572	0.051060384265325026	0.04750868962308477
GAD_DISEASE	cerebral infarct, atherothrombotic	3	3.488372093023256	0.0033225530524183078	9388, 2244, 348	76	15	12924	34.01052631578948	0.9883173404910572	0.051060384265325026	0.04750868962308477
GOTERM_MF_DIRECT	GO:0050660~flavin adenine dinucleotide binding	4	4.651162790697675	0.0033408510761974725	2328, 2330, 2671, 2329	84	68	18883	13.223389355742297	0.5754348074130609	0.05879584760363536	0.055121107128408155
UP_SEQ_FEATURE	CARBOHYD:O-linked (GalNAc...) serine	4	4.651162790697675	0.003344755590702523	348, 2243, 7018, 3698	84	74	20562	13.23166023166023	0.8478522705766435	0.19656768350805026	0.19586815438524582
REACTOME_PATHWAY	R-HSA-6802955~Paradoxical activation of RAF signaling by kinase inactive BRAF	4	4.651162790697675	0.003371730089729897	2335, 2244, 2266, 2243	72	47	11044	13.05437352245863	0.7659671263823761	0.03536204728253307	0.03157913059649464
REACTOME_PATHWAY	R-HSA-9649948~Signaling downstream of RAS mutants	4	4.651162790697675	0.003371730089729897	2335, 2244, 2266, 2243	72	47	11044	13.05437352245863	0.7659671263823761	0.03536204728253307	0.03157913059649464
REACTOME_PATHWAY	R-HSA-6802946~Signaling by moderate kinase activity BRAF mutants	4	4.651162790697675	0.003371730089729897	2335, 2244, 2266, 2243	72	47	11044	13.05437352245863	0.7659671263823761	0.03536204728253307	0.03157913059649464
REACTOME_PATHWAY	R-HSA-6802949~Signaling by RAS mutants	4	4.651162790697675	0.003371730089729897	2335, 2244, 2266, 2243	72	47	11044	13.05437352245863	0.7659671263823761	0.03536204728253307	0.03157913059649464
GOTERM_MF_DIRECT	GO:0004180~carboxypeptidase activity	3	3.488372093023256	0.0034450691955255097	10404, 1522, 5476	84	20	18883	33.71964285714285	0.5866499144901816	0.05879584760363536	0.055121107128408155
UP_KW_PTM	KW-0765~Sulfation	4	4.651162790697675	0.003730261811056715	2335, 2266, 2331, 4060	75	60	14237	12.655111111111111	0.0823657989075195	0.02984209448845372	0.026111832677397008
UP_SEQ_FEATURE	REPEAT:TPR 6	4	4.651162790697675	0.0037417903359532835	3437, 3434, 3433, 23523	84	77	20562	12.716141001855288	0.8783771347058758	0.19656768350805026	0.19586815438524582
GAD_DISEASE	fetal loss, late	3	3.488372093023256	0.003782980127522568	2244, 348, 338	76	16	12924	31.88486842105263	0.9937014478480385	0.05682971270222105	0.05287671099593342
GAD_DISEASE	recurrent pregnancy loss	3	3.488372093023256	0.003782980127522568	2244, 348, 338	76	16	12924	31.88486842105263	0.9937014478480385	0.05682971270222105	0.05287671099593342
UP_KW_BIOLOGICAL_PROCESS	KW-0391~Immunity	12	13.953488372093023	0.00395500779019862	10437, 3437, 730, 3434, 3433, 2267, 2244, 2243, 727, 5648, 3669, 383	54	961	11447	2.6470112151693836	0.2021880990678253	0.02817943050516517	0.022741294793642064
WIKIPATHWAYS	WP15:Selenium micronutrient network	5	5.813953488372093	0.003993621457741391	335, 2244, 2266, 338, 2243	64	87	8414	7.555675287356322	0.5632239875642766	0.05279992643793751	0.04820862848681251
GOTERM_CC_DIRECT	GO:0043231~intracellular membrane-bounded organelle	11	12.790697674418606	0.004025394573081311	10404, 10437, 1558, 2328, 1514, 1522, 9665, 5476, 338, 8529, 4758	85	912	20521	2.9119066047471622	0.42686014837979747	0.026608924062213237	0.02236692167548359
UP_SEQ_FEATURE	REPEAT:TPR 2	5	5.813953488372093	0.004028208241071061	3437, 143941, 3434, 3433, 23523	84	160	20562	7.64955357142857	0.8965249697585351	0.19656768350805026	0.19586815438524582
UP_SEQ_FEATURE	REPEAT:TPR 1	5	5.813953488372093	0.004028208241071061	3437, 143941, 3434, 3433, 23523	84	160	20562	7.64955357142857	0.8965249697585351	0.19656768350805026	0.19586815438524582
GOTERM_CC_DIRECT	GO:1903561~extracellular vesicle	5	5.813953488372093	0.0040491840964237535	335, 2244, 348, 2243, 116519	85	158	20521	7.639985107967238	0.4287462573371592	0.026608924062213237	0.02236692167548359
REACTOME_PATHWAY	R-HSA-2022857~Keratan sulfate degradation	3	3.488372093023256	0.004053478482187754	2588, 2331, 4060	72	15	11044	30.677777777777774	0.8256233947198446	0.04149989874620796	0.03706037469428804
WIKIPATHWAYS	WP5110:Familial hyperlipidemia type 3	3	3.488372093023256	0.004081153734333334	335, 336, 348	64	13	8414	30.338942307692307	0.5710982488654315	0.05279992643793751	0.04820862848681251
GOTERM_BP_DIRECT	GO:0045921~positive regulation of exocytosis	3	3.488372093023256	0.0041042918879852985	2244, 2266, 2243	85	22	19256	30.891978609625664	0.9638102464773002	0.0946332443886896	0.09099801443075976
UP_KW_MOLECULAR_FUNCTION	KW-0645~Protease	9	10.465116279069768	0.004111517115451815	10404, 1514, 1522, 5476, 5641, 59342, 54504, 4018, 5648	57	552	11872	3.3958810068649883	0.13428518920926402	0.023983849840135588	0.02124283842983438
UP_SEQ_FEATURE	ACT_SITE:Nucleophile	7	8.13953488372093	0.004156554446591061	10404, 9388, 57733, 2588, 5641, 51733, 4758	84	376	20562	4.55718085106383	0.9037543898279776	0.19656768350805026	0.19586815438524582
GAD_DISEASE	Alzheimer's Disease	6	6.976744186046512	0.004179434285740167	341, 344, 335, 348, 7018, 4018	76	183	12924	5.575496117342536	0.9963007064732514	0.0620878182226067	0.0577690694606752
GOTERM_MF_DIRECT	GO:0004497~monooxygenase activity	4	4.651162790697675	0.004240541944250824	1558, 5053, 2330, 8529	84	74	18883	12.15122265122265	0.6630723252368838	0.06784867110801318	0.06360812916376235
REACTOME_PATHWAY	R-HSA-597592~Post-translational protein modification	19	22.093023255813954	0.0042843260114639025	6694, 7057, 5476, 2243, 116519, 81027, 1522, 2335, 335, 23142, 336, 2266, 348, 338, 7018, 4148, 3698, 2719, 4758	72	1462	11044	1.9934260525915795	0.8421670233225714	0.04284326011463903	0.03826002763725904
GAD_DISEASE	dementia	4	4.651162790697675	0.0043869980238379945	9388, 335, 348, 338	76	57	12924	11.933518005540165	0.9972005152461448	0.06375452562903694	0.05931984284407028
GAD_DISEASE	stroke, ischemic	4	4.651162790697675	0.0043869980238379945	2244, 348, 2243, 116519	76	57	12924	11.933518005540165	0.9972005152461448	0.06375452562903694	0.05931984284407028
REACTOME_PATHWAY	R-HSA-168898~Toll-like Receptor Cascades	6	6.976744186046512	0.004450788237921533	1514, 5641, 2244, 2266, 338, 2243	72	168	11044	5.478174603174603	0.853115786814034	0.04349633959786953	0.03884324280367883
UP_SEQ_FEATURE	REPEAT:TPR 5	4	4.651162790697675	0.004465135043606117	3437, 3434, 3433, 23523	84	82	20562	11.940766550522648	0.9191391130354053	0.19656768350805026	0.19586815438524582
UP_SEQ_FEATURE	REGION:O-glycosylated at one site	3	3.488372093023256	0.004546939298228921	5176, 344, 336	84	25	20562	29.374285714285712	0.9227885205159193	0.19656768350805026	0.19586815438524582
GAD_DISEASE	Recurrence|Venous Thromboembolism	4	4.651162790697675	0.004607191457179354	348, 338, 4018, 727	76	58	12924	11.727767695099818	0.9979172131203119	0.06623456965858922	0.06162737820140986
GAD_DISEASE	Fredrickson hyperlipoproteinemia	3	3.488372093023256	0.00478725647948515	348, 338, 116519	76	18	12924	28.342105263157894	0.9983647041626099	0.06809108418161325	0.06335475596254815
GOTERM_BP_DIRECT	GO:0030301~cholesterol transport	3	3.488372093023256	0.004876204458152494	335, 336, 338	85	24	19256	28.31764705882353	0.9806434123371308	0.10635397291159628	0.10226850431152257
GOTERM_BP_DIRECT	GO:0010596~negative regulation of endothelial cell migration	3	3.488372093023256	0.004876204458152494	7057, 5176, 348	85	24	19256	28.31764705882353	0.9806434123371308	0.10635397291159628	0.10226850431152257
GOTERM_CC_DIRECT	GO:0005829~cytosol	35	40.69767441860465	0.0049410042652527075	5264, 130013, 59342, 2330, 2671, 2194, 23523, 10437, 122622, 57447, 3437, 83758, 1610, 335, 3434, 336, 3433, 338, 55902, 635, 6822, 32, 5053, 5232, 26007, 383, 57733, 3248, 56288, 3422, 27232, 5424, 5105, 51733, 5648	85	5537	20521	1.5260652933739867	0.495177648701814	0.030993572209312436	0.02605256794405973
GOTERM_MF_DIRECT	GO:0050750~low-density lipoprotein particle receptor binding	3	3.488372093023256	0.004947766262721676	348, 338, 116519	84	24	18883	28.09970238095238	0.71910434908189	0.07450753901510289	0.06985081782665896
BIOCARTA	h_lectinPathway:Lectin Induced Complement Pathway	3	3.488372093023256	0.005107175511603007	730, 727, 5648	15	13	1623	24.969230769230773	0.09270258546472998	0.03064305306961804	0.022131093883613027
BIOCARTA	h_fibrinolysisPathway:Fibrinolysis Pathway	3	3.488372093023256	0.005107175511603007	2244, 2266, 2243	15	13	1623	24.969230769230773	0.09270258546472998	0.03064305306961804	0.022131093883613027
BIOCARTA	h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway	3	3.488372093023256	0.005107175511603007	2244, 2266, 2243	15	13	1623	24.969230769230773	0.09270258546472998	0.03064305306961804	0.022131093883613027
REACTOME_PATHWAY	R-HSA-5602498~MyD88 deficiency (TLR2/4)	3	3.488372093023256	0.005206836804151015	2244, 2266, 2243	72	17	11044	27.06862745098039	0.8940501103379779	0.04975421835077637	0.044431674062088665
KEGG_PATHWAY	hsa00430:Taurine and hypotaurine metabolism	3	3.488372093023256	0.005319544890422229	2328, 2330, 2329	61	16	8662	26.625	0.48660923872541895	0.09499187304325409	0.09119219812152392
GAD_DISEASE	Cerebral Infarction	3	3.488372093023256	0.005330447115740225	2244, 348, 2243	76	19	12924	26.850415512465375	0.9992118878062273	0.07501902940783875	0.06980080223137726
REACTOME_PATHWAY	R-HSA-8978868~Fatty acid metabolism	6	6.976744186046512	0.0055442250014066125	1558, 5264, 3248, 2194, 8529, 32	72	177	11044	5.199623352165725	0.908429859932654	0.05182645110010529	0.04628222609869868
GAD_DISEASE	Metabolic Syndrome X	4	4.651162790697675	0.005554392234067751	335, 348, 338, 116519	76	62	12924	10.97113752122241	0.9994167666427886	0.07735648350988109	0.07197566603312795
GAD_DISEASE	normal variation	7	8.13953488372093	0.005752542108955915	1558, 335, 2244, 348, 338, 4018, 116519	76	281	12924	4.236186551788724	0.9995531804936822	0.07929019381107277	0.073774869933414
REACTOME_PATHWAY	R-HSA-5603041~IRAK4 deficiency (TLR2/4)	3	3.488372093023256	0.005833456896137271	2244, 2266, 2243	72	18	11044	25.564814814814813	0.9191962032743142	0.05336992479444737	0.047660584002483235
UP_KW_PTM	KW-0865~Zymogen	6	6.976744186046512	0.006048106152062898	10404, 1514, 1522, 5476, 5641, 54504	75	223	14237	5.107443946188341	0.13023203573102837	0.03628863691237739	0.031752557298330215
WIKIPATHWAYS	WP5109:Familial hyperlipidemia type 2	3	3.488372093023256	0.006188642877006203	335, 336, 338	64	16	8414	24.650390625	0.72335757297844	0.07535582797295788	0.0688031472796572
UP_KW_DOMAIN	KW-0802~TPR repeat	5	5.813953488372093	0.0064564564061058	3437, 143941, 3434, 3433, 23523	64	172	14600	6.631540697674419	0.09844860871560723	0.0516516512488464	0.0516516512488464
GAD_DISEASE	cholesterol, HDL	3	3.488372093023256	0.00649730765317824	9388, 335, 348	76	21	12924	24.293233082706767	0.999835934349493	0.0877464680030233	0.0816429365712498
GAD_DISEASE	carotid atherosclerosis	3	3.488372093023256	0.00649730765317824	335, 348, 338	76	21	12924	24.293233082706767	0.999835934349493	0.0877464680030233	0.0816429365712498
GOTERM_BP_DIRECT	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	3.488372093023256	0.0066033230622936845	2244, 2266, 2243	85	28	19256	24.272268907563028	0.9952354572849594	0.14023372924397376	0.1348468077984184
GAD_DISEASE	restenosis	4	4.651162790697675	0.006610378989896369	2244, 348, 338, 4018	76	66	12924	10.30622009569378	0.9998590940064311	0.08838076709491445	0.08223311463431082
GOTERM_MF_DIRECT	GO:0005319~lipid transporter activity	3	3.488372093023256	0.006699680688940196	336, 348, 338	84	28	18883	24.085459183673468	0.8210930462561401	0.09528434757603833	0.08932907585253595
GOTERM_CC_DIRECT	GO:0005783~endoplasmic reticulum	12	13.953488372093023	0.006963963517825337	10404, 341, 2328, 7057, 1522, 5476, 3433, 2244, 348, 2243, 5105, 2330	85	1147	20521	2.5257910662085234	0.6187838954051674	0.04178378110695202	0.03512259861164083
GAD_DISEASE	C-reactive protein	3	3.488372093023256	0.007120335583273412	341, 348, 116519	76	22	12924	23.188995215311003	0.9999290789182286	0.09333224191016228	0.08684017123129534
GAD_DISEASE	thrombosis, deep vein	3	3.488372093023256	0.007120335583273412	2244, 2266, 2243	76	22	12924	23.188995215311003	0.9999290789182286	0.09333224191016228	0.08684017123129534
REACTOME_PATHWAY	R-HSA-168249~Innate Immune System	15	17.441860465116278	0.007292839147412204	5476, 5641, 2243, 26007, 383, 1514, 1522, 730, 2588, 2244, 2266, 338, 727, 5648, 4758	72	1068	11044	2.154338327091136	0.9570368117668121	0.065331684028901	0.05834271317929763
GOTERM_MF_DIRECT	GO:0001968~fibronectin binding	3	3.488372093023256	0.007666287450824641	1514, 7057, 4018	84	30	18883	22.479761904761904	0.8605614210805561	0.09812847937055541	0.09199544940989568
GOTERM_MF_DIRECT	GO:0031210~phosphatidylcholine binding	3	3.488372093023256	0.007666287450824641	341, 336, 116519	84	30	18883	22.479761904761904	0.8605614210805561	0.09812847937055541	0.09199544940989568
GAD_DISEASE	cardiovascular risk	3	3.488372093023256	0.007769338531730655	2244, 348, 338	76	23	12924	22.180778032036613	0.9999704127863848	0.10085053997013481	0.09383550615022267
GAD_DISEASE	Cleft Lip|Cleft Palate	8	9.30232558139535	0.007870456089714688	344, 2335, 335, 27232, 348, 338, 635, 116519	76	395	12924	3.4441039307128576	0.9999741817247693	0.1011807672302744	0.09414276322697185
UP_SEQ_FEATURE	REPEAT:TPR 4	4	4.651162790697675	0.007954861555766392	3437, 3434, 3433, 23523	84	101	20562	9.694483734087694	0.9887626102587362	0.3193308710243366	0.3181944622306557
REACTOME_PATHWAY	R-HSA-2132295~MHC class II antigen presentation	5	5.813953488372093	0.008016935262706262	81027, 10437, 1514, 5476, 5641	72	123	11044	6.235320686540199	0.9686071394383917	0.07035269720334067	0.0628265947118205
GOTERM_BP_DIRECT	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	3	3.488372093023256	0.008054736525735807	10437, 1514, 5641	85	31	19256	21.92333965844402	0.998535867545786	0.16250430940671992	0.15626188859927465
GOTERM_BP_DIRECT	GO:0045907~positive regulation of vasoconstriction	3	3.488372093023256	0.008054736525735807	2244, 2266, 2243	85	31	19256	21.92333965844402	0.998535867545786	0.16250430940671992	0.15626188859927465
GOTERM_CC_DIRECT	GO:0034360~chylomicron remnant	2	2.3255813953488373	0.008170178544927778	348, 338	85	2	20521	241.4235294117647	0.6776494808008148	0.046978526633334725	0.03948919630048426
GAD_DISEASE	hypercholesterolemia	3	3.488372093023256	0.00844400232096556	348, 338, 116519	76	24	12924	21.25657894736842	0.9999880832546046	0.1075202962202948	0.10004132273601103
UP_KW_PTM	KW-1015~Disulfide bond	31	36.04651162790697	0.008625143077675979	9388, 6694, 5641, 2331, 2671, 10437, 1514, 3959, 730, 2588, 11309, 336, 2267, 2244, 2266, 338, 7018, 4148, 3698, 5858, 7057, 5476, 2243, 4060, 1522, 2335, 4059, 2719, 4018, 727, 5648	75	3870	14237	1.5205753660637382	0.18064576127507848	0.0414006867728447	0.03622560092623911
REACTOME_PATHWAY	R-HSA-140875~Common Pathway of Fibrin Clot Formation	3	3.488372093023256	0.008662694566199773	2244, 2266, 2243	72	22	11044	20.916666666666664	0.9762740653262403	0.07449917326931804	0.06652949426841426
GOTERM_BP_DIRECT	GO:0010902~positive regulation of very-low-density lipoprotein particle remodeling	2	2.3255813953488373	0.00870574949248976	344, 116519	85	2	19256	226.54117647058823	0.9991380383614452	0.1713546302546155	0.16477223429687934
REACTOME_PATHWAY	R-HSA-6802952~Signaling by BRAF and RAF1 fusions	4	4.651162790697675	0.009091545649717063	2335, 2244, 2266, 2243	72	67	11044	9.1575456053068	0.980302118040778	0.07665420841918308	0.06845399077434024
GAD_DISEASE	Acute Coronary Syndrome|	4	4.651162790697675	0.009399126332783666	7057, 335, 2244, 348	76	75	12924	9.069473684210527	0.9999967147318352	0.11855313119746944	0.11030672790549888
WIKIPATHWAYS	WP3896:Dengue 2 interactions with complement and coagulation cascades	4	4.651162790697675	0.00965455042500764	730, 336, 2244, 5648	64	59	8414	8.913135593220339	0.8657701641062366	0.11102732988758786	0.10137277946258022
GAD_DISEASE	quantitative traits	3	3.488372093023256	0.009869069122462463	341, 344, 348	76	26	12924	19.621457489878544	0.9999982580195745	0.12331724688534873	0.11473945783498415
UP_KW_PTM	KW-0325~Glycoprotein	36	41.86046511627907	0.010497057693493034	9388, 5641, 59342, 2331, 10437, 1514, 3959, 730, 2588, 335, 11309, 336, 2244, 2266, 338, 7018, 3698, 5858, 7057, 5176, 5476, 2243, 1291, 4060, 10404, 344, 1522, 2335, 348, 4059, 54504, 2719, 4018, 727, 5648, 4758	75	4801	14237	1.4234034576129972	0.21549978249319357	0.04198823077397214	0.03673970192722562
GOTERM_CC_DIRECT	GO:0005777~peroxisome	4	4.651162790697675	0.010685124929644487	5264, 1610, 9665, 3422	85	111	20521	8.699947005829358	0.7729265332764512	0.05898188961163756	0.04957897967355042
GOTERM_BP_DIRECT	GO:0006695~cholesterol biosynthetic process	3	3.488372093023256	0.010760349143841393	335, 3158, 3422	85	36	19256	18.87843137254902	0.9998384440320542	0.2067524228352382	0.19881026037192667
GAD_DISEASE	coronary artery disease	4	4.651162790697675	0.010827600202475057	335, 348, 338, 4018	76	79	12924	8.610259826782144	0.9999995228546698	0.13002699871070883	0.1209824879552145
GOTERM_BP_DIRECT	GO:2000352~negative regulation of endothelial cell apoptotic process	3	3.488372093023256	0.011343282164981656	2244, 2266, 2243	85	37	19256	18.368203497615262	0.9998995994687755	0.2128843885381441	0.20470667348897129
GAD_DISEASE	Thrombosis	3	3.488372093023256	0.011393075940746573	2244, 348, 338	76	28	12924	18.219924812030076	0.999999777864892	0.13002699871070883	0.1209824879552145
GAD_DISEASE	Myocardial Infarction|Stroke|Thrombosis	2	2.3255813953488373	0.011573083654879844	2244, 2243	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	Apoplexy|Hypoxia-Ischemia, Brain|Stroke	2	2.3255813953488373	0.011573083654879844	348, 338	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	type III hyperlipoproteinemia	2	2.3255813953488373	0.011573083654879844	344, 348	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	Aalpha and gamma fibrinogen plasma levels	2	2.3255813953488373	0.011573083654879844	2266, 2243	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	heart disease, ischemic; lipoprotein	2	2.3255813953488373	0.011573083654879844	335, 4018	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	atherosclerosis, coronary; longevity	2	2.3255813953488373	0.011573083654879844	348, 338	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	Spina Bifida Cystica	2	2.3255813953488373	0.011573083654879844	348, 338	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	Hypertriglyceridemia|Pancreatitis	2	2.3255813953488373	0.011573083654879844	348, 116519	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	post-trauma fibrinogen increase	2	2.3255813953488373	0.011573083654879844	2244, 2243	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
GAD_DISEASE	atherosclerosis, coronary atherosclerosis, generalized	2	2.3255813953488373	0.011573083654879844	2266, 2243	76	2	12924	170.05263157894737	0.999999825866937	0.13002699871070883	0.1209824879552145
WIKIPATHWAYS	WP272:Blood clotting cascade	3	3.488372093023256	0.011574653084780584	2244, 2266, 2243	64	22	8414	17.92755681818182	0.9101781744430887	0.11354724572385906	0.10367357218265393
WIKIPATHWAYS	WP357:Fatty acid biosynthesis	3	3.488372093023256	0.011574653084780584	55902, 2194, 32	64	22	8414	17.92755681818182	0.9101781744430887	0.11354724572385906	0.10367357218265393
WIKIPATHWAYS	WP702:Metapathway biotransformation Phase I and II	6	6.976744186046512	0.011960478170595538	1558, 2328, 2330, 6822, 8529, 2329	64	184	8414	4.287024456521739	0.917151703602919	0.11354724572385906	0.10367357218265393
BIOCARTA	h_compPathway:Complement Pathway	3	3.488372093023256	0.012018072121902352	730, 727, 5648	15	20	1623	16.23	0.2052491323266722	0.0473040338384808	0.0341640244389028
UP_KW_CELLULAR_COMPONENT	KW-0576~Peroxisome	4	4.651162790697675	0.01210322606616568	5264, 1610, 9665, 3422	80	108	17910	8.291666666666668	0.3060199015708809	0.0453870977481213	0.03479677494022633
REACTOME_PATHWAY	R-HSA-71387~Metabolism of carbohydrates	7	8.13953488372093	0.01229835254822745	5232, 2588, 2331, 5105, 26007, 2719, 4060	72	299	11044	3.591044221479004	0.9951125243399218	0.10169791530265007	0.09081860343306425
GOTERM_BP_DIRECT	GO:0042594~response to starvation	3	3.488372093023256	0.012549930141978683	122622, 3158, 5105	85	39	19256	17.4262443438914	0.9999625267024136	0.22860026685398008	0.21981884396367848
WIKIPATHWAYS	WP545:Complement activation	3	3.488372093023256	0.01261636063598434	730, 727, 5648	64	23	8414	17.148097826086957	0.9277917446778501	0.11354724572385906	0.10367357218265393
WIKIPATHWAYS	WP691:Tamoxifen metabolism	3	3.488372093023256	0.01261636063598434	1558, 2328, 6822	64	23	8414	17.148097826086957	0.9277917446778501	0.11354724572385906	0.10367357218265393
UP_SEQ_FEATURE	CARBOHYD:N-linked (GlcNAc...) asparagine	28	32.55813953488372	0.012931170418503786	9388, 5641, 59342, 2331, 10437, 1514, 3959, 730, 2588, 11309, 2244, 338, 3698, 5858, 7057, 5476, 2243, 1291, 10404, 1522, 2335, 4059, 54504, 2719, 4018, 727, 5648, 4758	84	4422	20562	1.5499773857982813	0.9993343285155405	0.48448785167994185	0.4827636956241414
GOTERM_BP_DIRECT	GO:0034447~very-low-density lipoprotein particle clearance	2	2.3255813953488373	0.013030498482383003	341, 348	85	3	19256	151.02745098039216	0.9999747004803902	0.22860026685398008	0.21981884396367848
GOTERM_BP_DIRECT	GO:0018158~protein oxidation	2	2.3255813953488373	0.013030498482383003	335, 336	85	3	19256	151.02745098039216	0.9999747004803902	0.22860026685398008	0.21981884396367848
GOTERM_MF_DIRECT	GO:0070653~high-density lipoprotein particle receptor binding	2	2.3255813953488373	0.013129280253237645	335, 336	84	3	18883	149.86507936507937	0.9660665890784973	0.1600521783251827	0.1500489171798588
OMIM_DISEASE	202400~Hypofibrinogenemia, congenital	2	2.3255813953488373	0.013213167362322833	2244, 2266	41	2	6035	147.1951219512195	0.6058748000814913	0.30830723845419944	0.30830723845419944
BIOCARTA	h_amiPathway:Acute Myocardial Infarction	3	3.488372093023256	0.01321777929443622	2244, 2266, 2243	15	21	1623	15.457142857142857	0.22338637746163348	0.0473040338384808	0.0341640244389028
REACTOME_PATHWAY	R-HSA-909733~Interferon alpha/beta signaling	4	4.651162790697675	0.013265116316350198	3437, 3434, 3433, 3669	72	77	11044	7.968253968253968	0.996792200391252	0.10762264181189783	0.09610952199015993
KEGG_PATHWAY	hsa00982:Drug metabolism - cytochrome P450	4	4.651162790697675	0.013434316607297294	1558, 2328, 2330, 2329	61	72	8662	7.888888888888889	0.8156043734544424	0.20991119698902022	0.2015147491094594
GAD_DISEASE	hypertension	8	9.30232558139535	0.013708965164558606	1558, 2328, 335, 2244, 348, 338, 2243, 8529	76	440	12924	3.0918660287081337	0.9999999903439543	0.15274072020845714	0.14211627220592424
UP_KW_PTM	KW-0654~Proteoglycan	4	4.651162790697675	0.01441052551791115	2331, 3698, 2719, 4060	75	98	14237	7.748027210884354	0.2838412422323423	0.049407516061409654	0.04323157655373345
GOTERM_MF_DIRECT	GO:0008234~cysteine-type peptidase activity	3	3.488372093023256	0.014666768317516229	1514, 1522, 5641	84	42	18883	16.056972789115648	0.9772342830915691	0.1706678495129161	0.16000110891835884
GAD_DISEASE	aging	3	3.488372093023256	0.014728279012545819	348, 338, 116519	76	32	12924	15.942434210526315	0.9999999975767623	0.16274139702292365	0.15142131480666943
GOTERM_BP_DIRECT	GO:0006508~proteolysis	8	9.30232558139535	0.014899475595701765	10404, 1514, 1522, 5476, 5641, 59342, 54504, 4018	85	593	19256	3.056204741593096	0.9999945197034424	0.2558271660793899	0.24599985238860786
GAD_DISEASE	Coronary Disease|Coronary heart disease|Myocardial Infarction	4	4.651162790697675	0.014923245716404899	1558, 348, 338, 4018	76	89	12924	7.6428149024246	0.9999999981401213	0.16354409444945367	0.15216817763284995
INTERPRO	IPR011990:TPR-like_helical_dom_sf	5	5.813953488372093	0.015154355857869445	3437, 143941, 3434, 3433, 23523	86	230	20603	5.208038422649141	0.9962035168921977	0.3950957062944534	0.3875185283655187
GOTERM_MF_DIRECT	GO:0050661~NADP binding	3	3.488372093023256	0.015338797303116849	2328, 2330, 2329	84	43	18883	15.683554817275748	0.9808826566889829	0.17072748302599622	0.16005701533687147
UP_SEQ_FEATURE	SITE:Cleavage; by autolysis	3	3.488372093023256	0.015471986868864605	1514, 5641, 5648	84	47	20562	15.624620060790273	0.9998436205372767	0.5011151803026517	0.49933185225886995
BIOCARTA	h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway	3	3.488372093023256	0.0157680112794936	2244, 2266, 2243	15	23	1623	14.11304347826087	0.26064665107769347	0.0473040338384808	0.0341640244389028
WIKIPATHWAYS	WP2878:PPAR alpha pathway	3	3.488372093023256	0.015975572136378936	335, 336, 116519	64	26	8414	15.169471153846153	0.9643370639321184	0.13778930967626832	0.1258076305739841
UP_SEQ_FEATURE	CROSSLNK:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)	2	2.3255813953488373	0.016049952394035106	2335, 2243	84	4	20562	122.39285714285712	0.9998875771208152	0.5011151803026517	0.49933185225886995
UP_SEQ_FEATURE	CARBOHYD:N-linked (GlcNAc...) (keratan sulfate) asparagine	2	2.3255813953488373	0.016049952394035106	2331, 4060	84	4	20562	122.39285714285712	0.9998875771208152	0.5011151803026517	0.49933185225886995
REACTOME_PATHWAY	R-HSA-168256~Immune System	22	25.581395348837212	0.016412026149452273	5476, 5641, 2243, 26007, 383, 81027, 10437, 1514, 3437, 1522, 730, 2588, 2335, 3434, 3433, 2244, 2266, 338, 727, 5648, 3669, 4758	72	2054	11044	1.642918965703776	0.9991877675693357	0.12675111220313864	0.11319169089768658
REACTOME_PATHWAY	R-HSA-6802957~Oncogenic MAPK signaling	4	4.651162790697675	0.016738507057247207	2335, 2244, 2266, 2243	72	84	11044	7.304232804232804	0.9992958202967731	0.12675111220313864	0.11319169089768658
REACTOME_PATHWAY	R-HSA-5602358~Diseases associated with the TLR signaling cascade	3	3.488372093023256	0.016801891617625353	2244, 2266, 2243	72	31	11044	14.844086021505374	0.9993150722563238	0.12675111220313864	0.11319169089768658
REACTOME_PATHWAY	R-HSA-5260271~Diseases of Immune System	3	3.488372093023256	0.016801891617625353	2244, 2266, 2243	72	31	11044	14.844086021505374	0.9993150722563238	0.12675111220313864	0.11319169089768658
GAD_DISEASE	Schizophrenia	7	8.13953488372093	0.016926735629376848	1610, 348, 338, 2331, 7018, 2194, 23523	76	355	12924	3.353150481838399	0.9999999998777276	0.17532899344767106	0.16313333421757875
GAD_DISEASE	Atherosclerosis|Coronary Artery Disease|Diabetes mellitus type II|Diabetes Mellitus, Type 2|Diabetic Angiopathies|Fam hyperbetalipoproteinaemia|Hyperlipoproteinemia Type II|Hypertriglyceridemia	2	2.3255813953488373	0.01730996793948585	348, 338	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	serum lipids	2	2.3255813953488373	0.01730996793948585	335, 348	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	Cerebral Hemorrhage|	2	2.3255813953488373	0.01730996793948585	348, 338	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	Hyperlipidemias|Obesity	2	2.3255813953488373	0.01730996793948585	348, 338	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	paraoxonase-1 specific activity	2	2.3255813953488373	0.01730996793948585	341, 335	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	holoprosencephaly	2	2.3255813953488373	0.01730996793948585	348, 338	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	Choroid Diseases|Macular Degeneration	2	2.3255813953488373	0.01730996793948585	5176, 348	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	Thromboembolism|Thrombosis|Venous Thrombosis	2	2.3255813953488373	0.01730996793948585	2266, 2243	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GAD_DISEASE	fibrinogen Il-6 myocardial infarct	2	2.3255813953488373	0.01730996793948585	2266, 2243	76	3	12924	113.36842105263158	0.9999999999274014	0.17532899344767106	0.16313333421757875
GOTERM_BP_DIRECT	GO:0010916~negative regulation of very-low-density lipoprotein particle clearance	2	2.3255813953488373	0.017336603407291335	341, 344	85	4	19256	113.27058823529411	0.9999992575677201	0.2743262539153747	0.26378831851094264
GOTERM_BP_DIRECT	GO:1902995~positive regulation of phospholipid efflux	2	2.3255813953488373	0.017336603407291335	335, 348	85	4	19256	113.27058823529411	0.9999992575677201	0.2743262539153747	0.26378831851094264
GOTERM_BP_DIRECT	GO:0010903~negative regulation of very-low-density lipoprotein particle remodeling	2	2.3255813953488373	0.017336603407291335	335, 336	85	4	19256	113.27058823529411	0.9999992575677201	0.2743262539153747	0.26378831851094264
GOTERM_BP_DIRECT	GO:0030300~regulation of intestinal cholesterol absorption	2	2.3255813953488373	0.017336603407291335	335, 336	85	4	19256	113.27058823529411	0.9999992575677201	0.2743262539153747	0.26378831851094264
GOTERM_MF_DIRECT	GO:0034190~apolipoprotein receptor binding	2	2.3255813953488373	0.01746774792983433	335, 336	84	4	18883	112.39880952380952	0.989015388785854	0.17886973880150353	0.16769038012640955
GOTERM_MF_DIRECT	GO:0060230~lipoprotein lipase activator activity	2	2.3255813953488373	0.01746774792983433	344, 116519	84	4	18883	112.39880952380952	0.989015388785854	0.17886973880150353	0.16769038012640955
GAD_DISEASE	Venous Thrombosis	3	3.488372093023256	0.017471714508462136	2244, 2266, 2243	76	35	12924	14.575939849624058	0.999999999941743	0.17563670900611936	0.16341964547764584
REACTOME_PATHWAY	R-HSA-382551~Transport of small molecules	11	12.790697674418606	0.018518430888295682	341, 9388, 344, 11309, 335, 336, 348, 338, 7018, 4018, 116519	72	735	11044	2.2956160241874533	0.9996769097310231	0.13729181520633005	0.12260478381216451
GOTERM_BP_DIRECT	GO:0050714~positive regulation of protein secretion	3	3.488372093023256	0.01862798558489352	2244, 2266, 2243	85	48	19256	14.158823529411764	0.9999997430959259	0.2849802521148886	0.27403305531741456
GOTERM_BP_DIRECT	GO:0006629~lipid metabolic process	5	5.813953488372093	0.018716175169874963	341, 9388, 55902, 2330, 4018	85	232	19256	4.88235294117647	0.9999997610678526	0.2849802521148886	0.27403305531741456
REACTOME_PATHWAY	R-HSA-4341670~Defective NEU1 causes sialidosis	2	2.3255813953488373	0.019164490743513285	5476, 4758	72	3	11044	102.25925925925927	0.9997565792991233	0.1396734071137409	0.12473160077134071
GAD_DISEASE	kidney aging	4	4.651162790697675	0.019783403220628694	5264, 730, 2335, 2330	76	99	12924	6.8708133971291865	0.9999999999975021	0.1973911201938848	0.1836608478094186
GOTERM_BP_DIRECT	GO:0051603~proteolysis involved in cellular protein catabolic process	3	3.488372093023256	0.02011686905600913	1514, 1522, 5641	85	50	19256	13.592470588235294	0.9999999245524884	0.29124551370261303	0.2800576439073454
GOTERM_CC_DIRECT	GO:0036021~endolysosome lumen	2	2.3255813953488373	0.020301929265671904	1514, 5641	85	5	20521	96.56941176470588	0.9410164525483196	0.1077563937947201	0.0905778382622285
UP_SEQ_FEATURE	REPEAT:TPR 8	3	3.488372093023256	0.02081813738268148	3437, 3434, 3433	84	55	20562	13.351948051948051	0.9999926682344724	0.6157785899508943	0.6135872070685068
GOTERM_BP_DIRECT	GO:0006084~acetyl-CoA metabolic process	2	2.3255813953488373	0.021624143679924514	3158, 32	85	5	19256	90.6164705882353	0.9999999782168018	0.29124551370261303	0.2800576439073454
GOTERM_BP_DIRECT	GO:0045833~negative regulation of lipid metabolic process	2	2.3255813953488373	0.021624143679924514	341, 344	85	5	19256	90.6164705882353	0.9999999782168018	0.29124551370261303	0.2800576439073454
GOTERM_BP_DIRECT	GO:0090205~positive regulation of cholesterol metabolic process	2	2.3255813953488373	0.021624143679924514	335, 348	85	5	19256	90.6164705882353	0.9999999782168018	0.29124551370261303	0.2800576439073454
GOTERM_BP_DIRECT	GO:0043152~induction of bacterial agglutination	2	2.3255813953488373	0.021624143679924514	2244, 2243	85	5	19256	90.6164705882353	0.9999999782168018	0.29124551370261303	0.2800576439073454
GOTERM_BP_DIRECT	GO:0072350~tricarboxylic acid metabolic process	2	2.3255813953488373	0.021624143679924514	5105, 32	85	5	19256	90.6164705882353	0.9999999782168018	0.29124551370261303	0.2800576439073454
GOTERM_BP_DIRECT	GO:0006633~fatty acid biosynthetic process	3	3.488372093023256	0.021653941539227735	9388, 2194, 32	85	52	19256	13.069683257918552	0.999999978745679	0.29124551370261303	0.2800576439073454
KEGG_PATHWAY	hsa05171:Coronavirus disease - COVID-19	6	6.976744186046512	0.022200689712114217	730, 2244, 2266, 2243, 727, 5648	61	233	8662	3.6566523605150216	0.9395751162429221	0.30834291266825303	0.29600919616152294
REACTOME_PATHWAY	R-HSA-1638074~Keratan sulfate/keratin metabolism	3	3.488372093023256	0.022300334808250433	2588, 2331, 4060	72	36	11044	12.782407407407407	0.9999385742342736	0.15981906612579477	0.1427221427728028
UP_KW_BIOLOGICAL_PROCESS	KW-0356~Hemostasis	3	3.488372093023256	0.02236170594193411	2244, 2266, 2243	54	50	11447	12.718888888888888	0.7244771270553533	0.12746172386902443	0.1028638473328969
UP_KW_BIOLOGICAL_PROCESS	KW-0094~Blood coagulation	3	3.488372093023256	0.02236170594193411	2244, 2266, 2243	54	50	11447	12.718888888888888	0.7244771270553533	0.12746172386902443	0.1028638473328969
GAD_DISEASE	Dyslipidemias|Nephrotic Syndrome	2	2.3255813953488373	0.023013996451702948	348, 338	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Neurodegenerative Diseases	2	2.3255813953488373	0.023013996451702948	348, 7018	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Cerebral Hemorrhage|Stroke	2	2.3255813953488373	0.023013996451702948	2266, 2243	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Fam hyperbetalipoproteinaemia|Hyperlipoproteinemia Type II	2	2.3255813953488373	0.023013996451702948	348, 338	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	atherosclerosis, coronary; lipoprotein	2	2.3255813953488373	0.023013996451702948	348, 116519	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Alzheimer's disease; chronic obstructive pulmonary disease/COPD	2	2.3255813953488373	0.023013996451702948	348, 7018	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Hypertriglyceridemia|Metabolic Syndrome X	2	2.3255813953488373	0.023013996451702948	348, 116519	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	cholesterol cholesterol, HDL triglycerides	2	2.3255813953488373	0.023013996451702948	335, 116519	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	Plasma Lipid Levels	2	2.3255813953488373	0.023013996451702948	348, 338	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
GAD_DISEASE	hyperlipidaemia	2	2.3255813953488373	0.023013996451702948	335, 116519	76	4	12924	85.02631578947368	0.9999999999999698	0.21367856427726972	0.19881535823554491
REACTOME_PATHWAY	R-HSA-9029569~NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	3	3.488372093023256	0.02347798207706469	341, 344, 348	72	37	11044	12.436936936936936	0.999963417182064	0.16550052939570192	0.14779582159988264
GOTERM_BP_DIRECT	GO:0065003~macromolecular complex assembly	4	4.651162790697675	0.023804483637800487	56288, 2244, 2266, 2243	85	141	19256	6.426700041718815	0.9999999964008118	0.31044156918109644	0.2985163044417978
GOTERM_BP_DIRECT	GO:0009410~response to xenobiotic stimulus	5	5.813953488372093	0.023850529478597247	7057, 336, 3158, 1291, 32	85	250	19256	4.530823529411765	0.9999999965352436	0.31044156918109644	0.2985163044417978
GAD_DISEASE	cardiovascular	3	3.488372093023256	0.02463347331650283	335, 348, 338	76	42	12924	12.146616541353383	0.9999999999999967	0.22713761258044335	0.21133821245330706
GOTERM_CC_DIRECT	GO:0016324~apical plasma membrane	6	6.976744186046512	0.024639024155224128	1514, 2335, 56288, 11309, 7018, 8529	85	402	20521	3.6033362598770853	0.9680241705638143	0.12593279012670108	0.1058565482224444
UP_KW_BIOLOGICAL_PROCESS	KW-0051~Antiviral defense	4	4.651162790697675	0.024953294864183545	3437, 3434, 3433, 3669	54	136	11447	6.23474945533769	0.7631633619407927	0.12930343702349656	0.104350142159313
UP_KW_DISEASE	KW-1008~Amyloidosis	3	3.488372093023256	0.02505674180335139	335, 348, 2243	39	31	4749	11.784119106699752	0.44214050377138137	0.24253113076599933	0.24253113076599933
GOTERM_BP_DIRECT	GO:0018206~peptidyl-methionine modification	2	2.3255813953488373	0.02589319837375674	335, 336	85	6	19256	75.51372549019608	0.9999999993609915	0.32147401673264137	0.3091249528928497
GOTERM_BP_DIRECT	GO:0042159~lipoprotein catabolic process	2	2.3255813953488373	0.02589319837375674	348, 338	85	6	19256	75.51372549019608	0.9999999993609915	0.32147401673264137	0.3091249528928497
GOTERM_BP_DIRECT	GO:0032914~positive regulation of transforming growth factor beta1 production	2	2.3255813953488373	0.02589319837375674	7057, 4060	85	6	19256	75.51372549019608	0.9999999993609915	0.32147401673264137	0.3091249528928497
REACTOME_PATHWAY	R-HSA-140877~Formation of Fibrin Clot (Clotting Cascade)	3	3.488372093023256	0.02590828961767221	2244, 2266, 2243	72	39	11044	11.799145299145298	0.9999874704805982	0.1768343577079214	0.15791719386009725
REACTOME_PATHWAY	R-HSA-9840310~Glycosphingolipid catabolism	3	3.488372093023256	0.02590828961767221	57733, 5476, 4758	72	39	11044	11.799145299145298	0.9999874704805982	0.1768343577079214	0.15791719386009725
GOTERM_MF_DIRECT	GO:0031406~carboxylic acid binding	2	2.3255813953488373	0.026088232382173095	5264, 5105	84	6	18883	74.93253968253968	0.9988491438999049	0.25686874960908895	0.24081445275852084
INTERPRO	IPR036188:FAD/NAD-bd_sf	3	3.488372093023256	0.027107976473612776	2328, 2330, 2329	86	62	20603	11.592085521380344	0.9999559856185991	0.6596274275245775	0.6469770385035583
GOTERM_CC_DIRECT	GO:0035580~specific granule lumen	3	3.488372093023256	0.027520151013988296	1522, 4758, 383	85	63	20521	11.496358543417367	0.9787419065244948	0.13563502999751376	0.11401205420080866
REACTOME_PATHWAY	R-HSA-3560782~Diseases associated with glycosaminoglycan metabolism	3	3.488372093023256	0.028436218729046944	2331, 2719, 4060	72	41	11044	11.223577235772357	0.9999959011117568	0.19105584458578415	0.17061731237428165
GAD_DISEASE	Cardiovascular Diseases|Fam hyperbetalipoproteinaemia|Hyperlipoproteinemia Type II	2	2.3255813953488373	0.028685354831708917	348, 338	76	5	12924	68.02105263157894	1.0	0.2573981168456028	0.2394938349707778
GAD_DISEASE	ischemia	2	2.3255813953488373	0.028685354831708917	348, 338	76	5	12924	68.02105263157894	1.0	0.2573981168456028	0.2394938349707778
GAD_DISEASE	Hyperlipoproteinemia Type III|Hypertriglyceridemia	2	2.3255813953488373	0.028685354831708917	348, 116519	76	5	12924	68.02105263157894	1.0	0.2573981168456028	0.2394938349707778
GAD_DISEASE	Cerebral Infarction|Intracranial Arteriosclerosis	2	2.3255813953488373	0.028685354831708917	348, 116519	76	5	12924	68.02105263157894	1.0	0.2573981168456028	0.2394938349707778
GOTERM_BP_DIRECT	GO:0051289~protein homotetramerization	3	3.488372093023256	0.029142436516554175	27232, 51733, 32	85	61	19256	11.141369334619094	0.9999999999568974	0.34262090015195856	0.32945950250052025
GOTERM_BP_DIRECT	GO:0030199~collagen fibril organization	3	3.488372093023256	0.029142436516554175	2331, 1291, 4060	85	61	19256	11.141369334619094	0.9999999999568974	0.34262090015195856	0.32945950250052025
GOTERM_BP_DIRECT	GO:0007584~response to nutrient	3	3.488372093023256	0.029142436516554175	9388, 3158, 32	85	61	19256	11.141369334619094	0.9999999999568974	0.34262090015195856	0.32945950250052025
REACTOME_PATHWAY	R-HSA-913531~Interferon Signaling	6	6.976744186046512	0.029209374440739257	81027, 10437, 3437, 3434, 3433, 3669	72	269	11044	3.4213135068153653	0.9999970893044398	0.1922033493654137	0.1716420608286485
UP_SEQ_FEATURE	REPEAT:TPR 7	3	3.488372093023256	0.029227877100430042	3437, 3434, 3433	84	66	20562	11.126623376623376	0.9999999424665247	0.8213033465220843	0.8183805588120412
WIKIPATHWAYS	WP2882:Nuclear receptors meta pathway	7	8.13953488372093	0.029423900217558915	11309, 335, 336, 5105, 6822, 2194, 116519	64	314	8414	2.930832006369427	0.9979340220101209	0.2318249203210385	0.2116662315974699
WIKIPATHWAYS	WP5333:Enterocyte cholesterol metabolism	3	3.488372093023256	0.029524721888383915	335, 3422, 338	64	36	8414	10.955729166666666	0.9979779743243287	0.2318249203210385	0.2116662315974699
SMART	SM00327:VWA	3	3.488372093023256	0.029701922197532402	4148, 3698, 1291	40	74	10690	10.834459459459458	0.8410665053991087	0.38057680754069173	0.3743378434826476
REACTOME_PATHWAY	R-HSA-2426168~Activation of gene expression by SREBF (SREBP)	3	3.488372093023256	0.02973590597866565	3422, 2194, 32	72	42	11044	10.956349206349206	0.9999976949369892	0.1922033493654137	0.1716420608286485
REACTOME_PATHWAY	R-HSA-1236975~Antigen processing-Cross presentation	4	4.651162790697675	0.0299479637383319	1514, 2244, 2266, 2243	72	105	11044	5.843386243386243	0.9999979017192017	0.1922033493654137	0.1716420608286485
GOTERM_BP_DIRECT	GO:0070995~NADPH oxidation	2	2.3255813953488373	0.030143846233939352	2330, 2329	85	7	19256	64.72605042016806	0.9999999999812582	0.34262090015195856	0.32945950250052025
GOTERM_BP_DIRECT	GO:0051006~positive regulation of lipoprotein lipase activity	2	2.3255813953488373	0.030143846233939352	344, 116519	85	7	19256	64.72605042016806	0.9999999999812582	0.34262090015195856	0.32945950250052025
GOTERM_BP_DIRECT	GO:0002719~negative regulation of cytokine production involved in immune response	2	2.3255813953488373	0.030143846233939352	335, 336	85	7	19256	64.72605042016806	0.9999999999812582	0.34262090015195856	0.32945950250052025
GOTERM_MF_DIRECT	GO:0035473~lipase binding	2	2.3255813953488373	0.030370410519194507	338, 116519	84	7	18883	64.22789115646258	0.9996275223842159	0.28795648492273307	0.2699592046150623
WIKIPATHWAYS	WP3925:Amino acid metabolism	4	4.651162790697675	0.03049441325745262	3158, 635, 5105, 383	64	91	8414	5.778846153846153	0.9983559484989659	0.2318249203210385	0.2116662315974699
REACTOME_PATHWAY	R-HSA-211945~Phase I - Functionalization of compounds	4	4.651162790697675	0.030681626170290983	1558, 2328, 55902, 8529	72	106	11044	5.788259958071278	0.9999984844461576	0.19401616548860473	0.17326094778517262
WIKIPATHWAYS	WP5355:Metabolic Epileptic Disorders	4	4.651162790697675	0.03135796023666221	5232, 5105, 2628, 383	64	92	8414	5.716032608695652	0.9986328821323904	0.2318249203210385	0.2116662315974699
GAD_DISEASE	Adenoma|Colorectal Neoplasms	3	3.488372093023256	0.031562905939068985	1558, 3248, 348	76	48	12924	10.62828947368421	1.0	0.2813307016035682	0.26176169992134546
UP_KW_DISEASE	KW-0380~Hyperlipidemia	2	2.3255813953488373	0.03163449531730426	344, 348	39	4	4749	60.88461538461539	0.5225761156680164	0.24253113076599933	0.24253113076599933
UP_KW_LIGAND	KW-0464~Manganese	5	5.813953488372093	0.031722685562085504	5105, 26007, 3669, 383, 32	37	233	6921	4.01403549472219	0.5674924615344055	0.2122222381006012	0.2122222381006012
REACTOME_PATHWAY	R-HSA-8866423~VLDL assembly	2	2.3255813953488373	0.031739174979873386	341, 338	72	5	11044	61.355555555555554	0.9999990522031833	0.19496921773350795	0.17411204560387686
REACTOME_PATHWAY	R-HSA-8964026~Chylomicron clearance	2	2.3255813953488373	0.031739174979873386	348, 338	72	5	11044	61.355555555555554	0.9999990522031833	0.19496921773350795	0.17411204560387686
GOTERM_BP_DIRECT	GO:0030168~platelet activation	3	3.488372093023256	0.03183707218474402	2244, 2266, 2243	85	64	19256	10.619117647058824	0.9999999999954249	0.35115905950662685	0.33766967803859044
GOTERM_MF_DIRECT	GO:0008047~enzyme activator activity	3	3.488372093023256	0.03227804612732567	344, 5476, 116519	84	64	18883	10.537388392857142	0.9997750158267784	0.29511356459269183	0.27666896680564856
GOTERM_CC_DIRECT	GO:0005579~membrane attack complex	2	2.3255813953488373	0.032287033419727704	730, 727	85	8	20521	60.35588235294117	0.9892099037241157	0.15364174523870425	0.12914813367891081
WIKIPATHWAYS	WP2911:miRNA targets in ECM and membrane receptors	3	3.488372093023256	0.032633885171368074	7057, 2335, 1291	64	38	8414	10.379111842105264	0.9989593366949596	0.23293842174045487	0.2126829068065023
UP_KW_LIGAND	KW-0408~Iron	6	6.976744186046512	0.032649575092400185	1558, 5053, 5264, 5424, 7018, 8529	37	348	6921	3.225069897483691	0.5781291716775245	0.2122222381006012	0.2122222381006012
REACTOME_PATHWAY	R-HSA-71291~Metabolism of amino acids and derivatives	7	8.13953488372093	0.033137055672473686	5053, 1610, 27232, 130013, 635, 2628, 383	72	375	11044	2.8632592592592596	0.9999994907701574	0.20068921041075613	0.179220132087745
GOTERM_BP_DIRECT	GO:0007155~cell adhesion	7	8.13953488372093	0.033296981330237826	7057, 3959, 2335, 56288, 4059, 1291, 83706	85	551	19256	2.878018575851393	0.9999999999986463	0.35115905950662685	0.33766967803859044
REACTOME_PATHWAY	R-HSA-9748784~Drug ADME	4	4.651162790697675	0.03371073469894455	1558, 11309, 5105, 6822	72	110	11044	5.5777777777777775	0.9999996054731107	0.20132799889647437	0.17979058506103757
GAD_DISEASE	inflammatory bowel disease	3	3.488372093023256	0.034024478692809404	2244, 348, 338	76	50	12924	10.203157894736842	1.0	0.29799670397964906	0.2772684366123287
GOTERM_CC_DIRECT	GO:0030669~clathrin-coated endocytic vesicle membrane	3	3.488372093023256	0.034291672143037334	348, 338, 7018	85	71	20521	10.200994200497101	0.9918951539544607	0.15774169185797174	0.13259446561974436
GAD_DISEASE	Biliary Tract Neoplasms|Gallstones	2	2.3255813953488373	0.03432422768351979	348, 338	76	6	12924	56.68421052631579	1.0	0.29799670397964906	0.2772684366123287
GAD_DISEASE	Cholesterol, HDL/blood*	2	2.3255813953488373	0.03432422768351979	335, 336	76	6	12924	56.68421052631579	1.0	0.29799670397964906	0.2772684366123287
GAD_DISEASE	memory disturbance	2	2.3255813953488373	0.03432422768351979	341, 348	76	6	12924	56.68421052631579	1.0	0.29799670397964906	0.2772684366123287
GOTERM_BP_DIRECT	GO:0010898~positive regulation of triglyceride catabolic process	2	2.3255813953488373	0.034376165676609075	344, 116519	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
GOTERM_BP_DIRECT	GO:0048261~negative regulation of receptor-mediated endocytosis	2	2.3255813953488373	0.034376165676609075	341, 344	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
GOTERM_BP_DIRECT	GO:0010757~negative regulation of plasminogen activation	2	2.3255813953488373	0.034376165676609075	7057, 1522	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
GOTERM_BP_DIRECT	GO:0032489~regulation of Cdc42 protein signal transduction	2	2.3255813953488373	0.034376165676609075	335, 348	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
GOTERM_BP_DIRECT	GO:0050996~positive regulation of lipid catabolic process	2	2.3255813953488373	0.034376165676609075	336, 116519	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
GOTERM_BP_DIRECT	GO:0006082~organic acid metabolic process	2	2.3255813953488373	0.034376165676609075	1558, 2329	85	8	19256	56.63529411764706	0.9999999999994504	0.35115905950662685	0.33766967803859044
UP_KW_CELLULAR_COMPONENT	KW-0473~Membrane attack complex	2	2.3255813953488373	0.03475423624912244	730, 727	80	8	17910	55.96875000000001	0.6539513746749361	0.11584745416374147	0.08881638152553512
GOTERM_MF_DIRECT	GO:0050839~cell adhesion molecule binding	3	3.488372093023256	0.035103535141802596	2244, 2266, 2243	84	67	18883	10.065565031982942	0.9998935702343252	0.2995501665433821	0.28082828113442077
GOTERM_MF_DIRECT	GO:0004197~cysteine-type endopeptidase activity	3	3.488372093023256	0.035103535141802596	1514, 1522, 5641	84	67	18883	10.065565031982942	0.9998935702343252	0.2995501665433821	0.28082828113442077
GAD_DISEASE	colorectal cancer	7	8.13953488372093	0.036990411224050335	1558, 2328, 7057, 5176, 3248, 348, 635	76	426	12924	2.794292068198666	1.0	0.3190721277842277	0.2968778810497975
GAD_DISEASE	Apoplexy|Brain Ischemia|Stroke	3	3.488372093023256	0.03785221105078034	348, 635, 8529	76	53	12924	9.625620655412114	1.0	0.32234653614581726	0.2999245257781576
GAD_DISEASE	stroke	3	3.488372093023256	0.03785221105078034	335, 2244, 348	76	53	12924	9.625620655412114	1.0	0.32234653614581726	0.2999245257781576
REACTOME_PATHWAY	R-HSA-8964041~LDL remodeling	2	2.3255813953488373	0.03796677880097278	338, 4018	72	6	11044	51.12962962962963	0.9999999408806196	0.21767619845891062	0.19438990746098064
REACTOME_PATHWAY	R-HSA-3000471~Scavenging by Class B Receptors	2	2.3255813953488373	0.03796677880097278	335, 338	72	6	11044	51.12962962962963	0.9999999408806196	0.21767619845891062	0.19438990746098064
REACTOME_PATHWAY	R-HSA-8964046~VLDL clearance	2	2.3255813953488373	0.03796677880097278	341, 338	72	6	11044	51.12962962962963	0.9999999408806196	0.21767619845891062	0.19438990746098064
GOTERM_MF_DIRECT	GO:0030145~manganese ion binding	3	3.488372093023256	0.03802142707825833	3422, 5105, 383	84	70	18883	9.634183673469387	0.9999509835264208	0.31398339780755263	0.2943594354445806
UP_KW_BIOLOGICAL_PROCESS	KW-0276~Fatty acid metabolism	4	4.651162790697675	0.03954825075529624	3248, 2194, 8529, 32	54	163	11447	5.201999545557827	0.899744904409852	0.18785419108765716	0.15160162789530227
UP_SEQ_FEATURE	CARBOHYD:N-linked (Glc) (glycation) lysine	2	2.3255813953488373	0.03964885490364794	335, 348	84	10	20562	48.957142857142856	0.999999999866435	1.0	0.9982174688057041
GAD_DISEASE	cholesterol; apoA-IV; apoE; triacylglycerols	2	2.3255813953488373	0.03993079858748829	348, 338	76	7	12924	48.58646616541353	1.0	0.33789542855361926	0.3143918572331357
INTERPRO	IPR016039:Thiolase-like	2	2.3255813953488373	0.04050724753529889	3158, 2194	86	10	20603	47.913953488372094	0.9999997212467094	0.7332882028456384	0.7192251414212015
INTERPRO	IPR025661:Pept_asp_AS	2	2.3255813953488373	0.04050724753529889	1514, 1522	86	10	20603	47.913953488372094	0.9999997212467094	0.7332882028456384	0.7192251414212015
WIKIPATHWAYS	WP4136:Fibrin complement receptor 3 signaling pathway	3	3.488372093023256	0.04093472712327629	2244, 2266, 2243	64	43	8414	9.172238372093023	0.9998251883741746	0.2824496171506064	0.25788878087664063
KEGG_PATHWAY	hsa00620:Pyruvate metabolism	3	3.488372093023256	0.04179471053854554	55902, 5105, 32	61	47	8662	9.063829787234043	0.9951880568386028	0.5224338817318193	0.5015365264625464
GAD_DISEASE	blood pressure, arterial	3	3.488372093023256	0.04183655096872578	2244, 348, 338	76	56	12924	9.109962406015038	1.0	0.351795400284191	0.3273249648119174
INTERPRO	IPR002035:VWF_A	3	3.488372093023256	0.04223347510251636	4148, 3698, 1291	86	79	20603	9.097586105387107	0.9999998555313361	0.7332882028456384	0.7192251414212015
GOTERM_BP_DIRECT	GO:0033622~integrin activation	2	2.3255813953488373	0.04278613129778916	2335, 83706	85	10	19256	45.30823529411765	0.9999999999999996	0.43160509946644815	0.4150254735885548
UP_KW_BIOLOGICAL_PROCESS	KW-0444~Lipid biosynthesis	4	4.651162790697675	0.0451957801403714	3158, 3422, 2194, 32	54	172	11447	4.929801894918174	0.9283663969899424	0.19816611292316694	0.159923529727468
UP_SEQ_FEATURE	DOMAIN:VWFA	3	3.488372093023256	0.045351061407174605	4148, 3698, 1291	84	84	20562	8.742346938775508	0.9999999999952993	1.0	0.9982174688057041
GAD_DISEASE	Cerebral Infarction|	2	2.3255813953488373	0.045505250093405204	338, 8529	76	8	12924	42.51315789473684	1.0	0.3709787766761144	0.3451739702207077
GAD_DISEASE	Femur Head Necrosis	2	2.3255813953488373	0.045505250093405204	335, 338	76	8	12924	42.51315789473684	1.0	0.3709787766761144	0.3451739702207077
GAD_DISEASE	Cardiovascular Diseases|Obesity|Virilism	2	2.3255813953488373	0.045505250093405204	348, 338	76	8	12924	42.51315789473684	1.0	0.3709787766761144	0.3451739702207077
GAD_DISEASE	Fetal Growth Retardation|Intrauterine growth retardation	2	2.3255813953488373	0.045505250093405204	348, 338	76	8	12924	42.51315789473684	1.0	0.3709787766761144	0.3451739702207077
GAD_DISEASE	Abortion, Spontaneous|Thrombosis	2	2.3255813953488373	0.045505250093405204	348, 338	76	8	12924	42.51315789473684	1.0	0.3709787766761144	0.3451739702207077
WIKIPATHWAYS	WP5090:Complement system in neuronal development and plasticity	4	4.651162790697675	0.04583423031721239	730, 56288, 727, 5648	64	107	8414	4.914719626168225	0.999939447329854	0.3060543766342892	0.2794409525791336
SMART	SM00645:Pept_C1	2	2.3255813953488373	0.04642859127430478	1514, 1522	40	13	10690	41.11538461538461	0.9449767194423004	0.38057680754069173	0.3743378434826476
KEGG_PATHWAY	hsa00330:Arginine and proline metabolism	3	3.488372093023256	0.046744777803614114	1610, 2628, 383	61	50	8662	8.52	0.9974814583216256	0.5226281924240742	0.5017230647271113
REACTOME_PATHWAY	R-HSA-1630316~Glycosaminoglycan metabolism	4	4.651162790697675	0.04731739697082105	2588, 2331, 2719, 4060	72	126	11044	4.8694885361552025	0.9999999991133731	0.2637879679403777	0.23556878997466282
UP_SEQ_FEATURE	DOMAIN:Peptidase C1A papain C-terminal	2	2.3255813953488373	0.04739020585333371	1514, 1522	84	12	20562	40.79761904761905	0.9999999999985867	1.0	0.9982174688057041
GOTERM_BP_DIRECT	GO:0071347~cellular response to interleukin-1	3	3.488372093023256	0.047733232511812204	2244, 2266, 5105	85	80	19256	8.49529411764706	1.0	0.4755644276176846	0.45729615344649716
UP_KW_MOLECULAR_FUNCTION	KW-0456~Lyase	4	4.651162790697675	0.04806063955204624	130013, 5105, 26007, 2194	57	173	11872	4.815738768887536	0.8216287119083132	0.24030319776023118	0.21283997515906192
WIKIPATHWAYS	WP4718:Cholesterol metabolism with Bloch and Kandutsch Russell pathways	3	3.488372093023256	0.048084300735498055	3158, 3422, 2194	64	47	8414	8.391622340425531	0.9999628561169576	0.31104532038275307	0.2839979012190354
GOTERM_CC_DIRECT	GO:0009986~cell surface	7	8.13953488372093	0.04852079426235576	9388, 7057, 2244, 2266, 2243, 7018, 2719	85	644	20521	2.6241687979539643	0.9989550305633279	0.21599579381306755	0.18156168175591186
REACTOME_PATHWAY	R-HSA-1655829~Regulation of cholesterol biosynthesis by SREBP (SREBF)	3	3.488372093023256	0.048634478259157225	3422, 2194, 32	72	55	11044	8.366666666666667	0.9999999995109137	0.2637879679403777	0.23556878997466282
GOTERM_BP_DIRECT	GO:0001889~liver development	3	3.488372093023256	0.04988804754667968	3158, 2671, 51733	85	82	19256	8.28809182209469	1.0	0.49097139475817686	0.47211127922223695
SMART	SM01359:A2M_N_2	2	2.3255813953488373	0.04991171246435301	727, 5858	40	14	10690	38.17857142857143	0.9559848872266296	0.38057680754069173	0.3743378434826476
SMART	SM01360:A2M	2	2.3255813953488373	0.04991171246435301	727, 5858	40	14	10690	38.17857142857143	0.9559848872266296	0.38057680754069173	0.3743378434826476
SMART	SM01361:A2M_recep	2	2.3255813953488373	0.04991171246435301	727, 5858	40	14	10690	38.17857142857143	0.9559848872266296	0.38057680754069173	0.3743378434826476
UP_SEQ_FEATURE	MOTIF:Cell attachment site	3	3.488372093023256	0.05029641626472232	7057, 2335, 1291	84	89	20562	8.251203852327448	0.9999999999997462	1.0	0.9982174688057041
REACTOME_PATHWAY	R-HSA-3656225~Defective CHST6 causes MCDC1	2	2.3255813953488373	0.05030375202583946	2331, 4060	72	8	11044	38.34722222222222	0.9999999997701574	0.2637879679403777	0.23556878997466282
REACTOME_PATHWAY	R-HSA-163765~ChREBP activates metabolic gene expression	2	2.3255813953488373	0.05030375202583946	2194, 32	72	8	11044	38.34722222222222	0.9999999997701574	0.2637879679403777	0.23556878997466282
REACTOME_PATHWAY	R-HSA-166665~Terminal pathway of complement	2	2.3255813953488373	0.05030375202583946	730, 727	72	8	11044	38.34722222222222	0.9999999997701574	0.2637879679403777	0.23556878997466282
REACTOME_PATHWAY	R-HSA-3656243~Defective ST3GAL3 causes MCT12 and EIEE15	2	2.3255813953488373	0.05030375202583946	2331, 4060	72	8	11044	38.34722222222222	0.9999999997701574	0.2637879679403777	0.23556878997466282
REACTOME_PATHWAY	R-HSA-3656244~Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	2	2.3255813953488373	0.05030375202583946	2331, 4060	72	8	11044	38.34722222222222	0.9999999997701574	0.2637879679403777	0.23556878997466282
BIOCARTA	h_slrpPathway:Small Leucine-rich Proteoglycan (SLRP) molecules	2	2.3255813953488373	0.05072915672055016	2331, 4060	15	6	1623	36.06666666666667	0.6281115469847363	0.13044640299570043	0.0942112910524503
GAD_DISEASE	Coronary Artery Disease|Hypertension	2	2.3255813953488373	0.05104776373769517	348, 338	76	9	12924	37.78947368421053	1.0	0.40625511974582407	0.3779965362481714
GAD_DISEASE	cognitive impairment	2	2.3255813953488373	0.05104776373769517	341, 348	76	9	12924	37.78947368421053	1.0	0.40625511974582407	0.3779965362481714
GAD_DISEASE	fluvastatin induced cholesterol changes	2	2.3255813953488373	0.05104776373769517	348, 338	76	9	12924	37.78947368421053	1.0	0.40625511974582407	0.3779965362481714
GAD_DISEASE	Cardiovascular Diseases|Coronary Disease|Myocardial Infarction|Stroke	2	2.3255813953488373	0.05104776373769517	348, 338	76	9	12924	37.78947368421053	1.0	0.40625511974582407	0.3779965362481714
GOTERM_BP_DIRECT	GO:0097267~omega-hydroxylase P450 pathway	2	2.3255813953488373	0.051123715958046	1558, 8529	85	12	19256	37.75686274509804	1.0	0.4911528425969419	0.4722857569457582
GOTERM_BP_DIRECT	GO:0009313~oligosaccharide catabolic process	2	2.3255813953488373	0.051123715958046	57733, 4758	85	12	19256	37.75686274509804	1.0	0.4911528425969419	0.4722857569457582
UP_KW_CELLULAR_COMPONENT	KW-0427~LDL	2	2.3255813953488373	0.05168138365957968	344, 338	80	12	17910	37.3125	0.7964700682666128	0.15504415097873903	0.11886718241703326
INTERPRO	IPR000668:Peptidase_C1A_C	2	2.3255813953488373	0.05234009943294663	1514, 1522	86	13	20603	36.856887298747765	0.9999999969927881	0.7332882028456384	0.7192251414212015
INTERPRO	IPR013128:Peptidase_C1A	2	2.3255813953488373	0.05234009943294663	1514, 1522	86	13	20603	36.856887298747765	0.9999999969927881	0.7332882028456384	0.7192251414212015
INTERPRO	IPR040839:MG4	2	2.3255813953488373	0.05234009943294663	727, 5858	86	13	20603	36.856887298747765	0.9999999969927881	0.7332882028456384	0.7192251414212015
INTERPRO	IPR002890:MG2	2	2.3255813953488373	0.05234009943294663	727, 5858	86	13	20603	36.856887298747765	0.9999999969927881	0.7332882028456384	0.7192251414212015
GOTERM_CC_DIRECT	GO:0005604~basement membrane	3	3.488372093023256	0.05259908542290974	5176, 2335, 1291	85	90	20521	8.047450980392156	0.9994223505684284	0.2243197515977922	0.1885586317778543
KEGG_PATHWAY	hsa05205:Proteoglycans in cancer	5	5.813953488372093	0.05318865972418524	1514, 7057, 2335, 2719, 4060	61	205	8662	3.463414634146341	0.9989212237606891	0.5226281924240742	0.5017230647271113
GOTERM_MF_DIRECT	GO:0005198~structural molecule activity	4	4.651162790697675	0.05331596820483561	2244, 2266, 348, 2243	84	193	18883	4.659018011349618	0.9999991899846702	0.4265277456386849	0.3998697615362671
REACTOME_PATHWAY	R-HSA-166658~Complement cascade	3	3.488372093023256	0.053479846681728636	730, 727, 5648	72	58	11044	7.933908045977011	0.9999999999455695	0.27376588182313466	0.24447929911647376
REACTOME_PATHWAY	R-HSA-1660662~Glycosphingolipid metabolism	3	3.488372093023256	0.053479846681728636	57733, 5476, 4758	72	58	11044	7.933908045977011	0.9999999999455695	0.27376588182313466	0.24447929911647376
GOTERM_CC_DIRECT	GO:0035578~azurophil granule lumen	3	3.488372093023256	0.05364167972990683	2588, 5476, 383	85	91	20521	7.9590174531350995	0.9995037809251817	0.2243197515977922	0.1885586317778543
GOTERM_BP_DIRECT	GO:0007596~blood coagulation	3	3.488372093023256	0.05430099142137381	2244, 2243, 8529	85	86	19256	7.902599179206566	1.0	0.5068102873929644	0.48734173855878615
KEGG_PATHWAY	hsa04611:Platelet activation	4	4.651162790697675	0.054353332012103725	2244, 2266, 2243, 83706	61	124	8662	4.580645161290323	0.9990750631528456	0.5226281924240742	0.5017230647271113
REACTOME_PATHWAY	R-HSA-211859~Biological oxidations	5	5.813953488372093	0.05439265566208768	1558, 2328, 55902, 6822, 8529	72	222	11044	3.454704704704705	0.9999999999640532	0.2751628462905612	0.2457268208734314
REACTOME_PATHWAY	R-HSA-2142753~Arachidonic acid metabolism	3	3.488372093023256	0.05513180888759669	1558, 3248, 8529	72	59	11044	7.799435028248587	0.999999999974318	0.27565904443798345	0.24616993735857126
GOTERM_BP_DIRECT	GO:0090181~regulation of cholesterol metabolic process	2	2.3255813953488373	0.055265557980893276	348, 2330	85	13	19256	34.8524886877828	1.0	0.5068102873929644	0.48734173855878615
GOTERM_BP_DIRECT	GO:0034379~very-low-density lipoprotein particle assembly	2	2.3255813953488373	0.055265557980893276	341, 338	85	13	19256	34.8524886877828	1.0	0.5068102873929644	0.48734173855878615
GOTERM_BP_DIRECT	GO:0010447~response to acidic pH	2	2.3255813953488373	0.055265557980893276	5176, 5641	85	13	19256	34.8524886877828	1.0	0.5068102873929644	0.48734173855878615
WIKIPATHWAYS	WP1533:Vitamin B12 metabolism	3	3.488372093023256	0.05565189495136251	335, 348, 338	64	51	8414	7.733455882352941	0.9999928821729637	0.3490891592403648	0.3187335801759853
GOTERM_MF_DIRECT	GO:0008035~high-density lipoprotein particle binding	2	2.3255813953488373	0.05567561151682199	335, 336	84	13	18883	34.58424908424908	0.9999995724088006	0.43190777419110393	0.4049135383041599
GOTERM_CC_DIRECT	GO:0031089~platelet dense granule lumen	2	2.3255813953488373	0.055824287503068455	6694, 3959	85	14	20521	34.4890756302521	0.9996391806633055	0.22658093163010137	0.19045933383399824
GAD_DISEASE	lung cancer	8	9.30232558139535	0.05589203639147386	3248, 2335, 336, 348, 338, 635, 5424, 5648	76	593	12924	2.294133309665394	1.0	0.4421754594994115	0.41141830337865964
INTERPRO	IPR036595:A-macroglobulin_rcpt-bd_sf	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
INTERPRO	IPR011625:A2M_N_BRD	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
INTERPRO	IPR009048:A-macroglobulin_rcpt-bd	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
INTERPRO	IPR041555:MG3	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
INTERPRO	IPR001599:Macroglobln_a2	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
INTERPRO	IPR011626:Alpha-macroglobulin_TED	2	2.3255813953488373	0.0562522456977476	727, 5858	86	14	20603	34.22425249169435	0.9999999993356226	0.7332882028456384	0.7192251414212015
REACTOME_PATHWAY	R-HSA-2142816~Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	2	2.3255813953488373	0.05641361371460233	1558, 8529	72	9	11044	34.08641975308642	0.9999999999856742	0.27882590686527586	0.24899801915410683
GOTERM_BP_DIRECT	GO:0031647~regulation of protein stability	3	3.488372093023256	0.05655762825529428	336, 5476, 7018	85	88	19256	7.722994652406416	1.0	0.5128315281126121	0.4931316800686332
GAD_DISEASE	Depression	2	2.3255813953488373	0.05655852004609429	348, 338	76	10	12924	34.01052631578947	1.0	0.44481612530369447	0.4138752878667135
UP_KW_BIOLOGICAL_PROCESS	KW-0179~Complement alternate pathway	2	2.3255813953488373	0.05857626268500789	730, 727	54	13	11447	32.61253561253561	0.967955519290204	0.2384890695032464	0.19246486310788305
UP_SEQ_FEATURE	REPEAT:TPR	3	3.488372093023256	0.06073247440383694	3437, 3433, 23523	84	99	20562	7.417748917748916	0.9999999999999994	1.0	0.9982174688057041
GAD_DISEASE	angina	2	2.3255813953488373	0.062037698535184	2244, 2243	76	11	12924	30.918660287081337	1.0	0.47396801680880574	0.4409994113015365
GAD_DISEASE	aspirin resistance	2	2.3255813953488373	0.062037698535184	2244, 338	76	11	12924	30.918660287081337	1.0	0.47396801680880574	0.4409994113015365
GAD_DISEASE	Biliary calculi|Gallstones	2	2.3255813953488373	0.062037698535184	335, 348	76	11	12924	30.918660287081337	1.0	0.47396801680880574	0.4409994113015365
GAD_DISEASE	cholelithiasis	2	2.3255813953488373	0.062037698535184	348, 338	76	11	12924	30.918660287081337	1.0	0.47396801680880574	0.4409994113015365
GAD_DISEASE	Gallbladder Diseases	2	2.3255813953488373	0.062037698535184	348, 338	76	11	12924	30.918660287081337	1.0	0.47396801680880574	0.4409994113015365
UP_SEQ_FEATURE	REGION:Heparin-binding	2	2.3255813953488373	0.06268842230111572	7057, 338	84	16	20562	30.59821428571428	0.9999999999999999	1.0	0.9982174688057041
REACTOME_PATHWAY	R-HSA-392499~Metabolism of proteins	20	23.25581395348837	0.06282050686638455	6694, 7057, 5476, 2243, 116519, 81027, 1522, 2335, 335, 23142, 336, 3158, 2266, 348, 338, 7018, 4148, 3698, 2719, 4758	72	2077	11044	1.4770234847269033	0.9999999999992347	0.3069638403698336	0.27412584814422347
GOTERM_BP_DIRECT	GO:0045723~positive regulation of fatty acid biosynthetic process	2	2.3255813953488373	0.06349572367144887	344, 116519	85	15	19256	30.20549019607843	1.0	0.5569679239441222	0.5355726257504818
GOTERM_BP_DIRECT	GO:0000302~response to reactive oxygen species	2	2.3255813953488373	0.06349572367144887	348, 1291	85	15	19256	30.20549019607843	1.0	0.5569679239441222	0.5355726257504818
GOTERM_BP_DIRECT	GO:0010884~positive regulation of lipid storage	2	2.3255813953488373	0.06349572367144887	338, 32	85	15	19256	30.20549019607843	1.0	0.5569679239441222	0.5355726257504818
UP_KW_MOLECULAR_FUNCTION	KW-0511~Multifunctional enzyme	3	3.488372093023256	0.06466076864717421	26007, 2194, 32	57	88	11872	7.100478468899521	0.9036347907569305	0.28289086283138715	0.25056047850780006
WIKIPATHWAYS	WP4720:Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	2	2.3255813953488373	0.06543447466347141	1558, 8529	64	9	8414	29.21527777777778	0.9999991754450496	0.39838047809819355	0.36373869739400283
UP_KW_PTM	KW-0971~Glycation	2	2.3255813953488373	0.06552955065099798	335, 348	75	13	14237	29.204102564102566	0.7896182019081963	0.19658865195299396	0.1720150704588697
GOTERM_CC_DIRECT	GO:0042470~melanosome	3	3.488372093023256	0.06557904099246964	5176, 348, 2194	85	102	20521	7.100692041522492	0.999913925440525	0.2585687901988803	0.2173476787178994
REACTOME_PATHWAY	R-HSA-1643685~Disease	18	20.930232558139537	0.0660347961810373	5053, 7057, 5476, 2243, 2331, 26007, 4060, 81027, 1514, 2328, 2588, 2335, 335, 2244, 2266, 2719, 5648, 4758	72	1818	11044	1.5187018701870187	0.9999999999998254	0.3190445208746746	0.28491417678110476
UP_SEQ_FEATURE	DISULFID:Interchain (between heavy and light chains)	2	2.3255813953488373	0.06647489465349725	1514, 5648	84	17	20562	28.79831932773109	1.0	1.0	0.9982174688057041
INTERPRO	IPR036465:vWFA_dom_sf	3	3.488372093023256	0.06648537425347512	4148, 3698, 1291	86	102	20603	7.046169630642955	0.9999999999875774	0.836798675948911	0.8207504821635894
KEGG_PATHWAY	hsa00590:Arachidonic acid metabolism	3	3.488372093023256	0.06656248389858319	1558, 3248, 8529	61	61	8662	6.9836065573770485	0.9998177546433408	0.5943078919516356	0.5705355762735701
GAD_DISEASE	hepatitis C	3	3.488372093023256	0.06707254195396313	2267, 348, 23523	76	73	12924	6.9884643114635905	1.0	0.5040675067563252	0.4690052194501635
GAD_DISEASE	cholesterol, HDL cholesterol, LDL	2	2.3255813953488373	0.0674854777183113	335, 348	76	12	12924	28.342105263157894	1.0	0.5040675067563252	0.4690052194501635
GAD_DISEASE	osteonecrosis	2	2.3255813953488373	0.0674854777183113	335, 338	76	12	12924	28.342105263157894	1.0	0.5040675067563252	0.4690052194501635
GAD_DISEASE	lipid concentrations	2	2.3255813953488373	0.0674854777183113	335, 338	76	12	12924	28.342105263157894	1.0	0.5040675067563252	0.4690052194501635
GOTERM_BP_DIRECT	GO:0006957~complement activation, alternative pathway	2	2.3255813953488373	0.06758419927802774	730, 727	85	16	19256	28.31764705882353	1.0	0.5864564388964343	0.5639283724704249
UP_KW_LIGAND	KW-0521~NADP	4	4.651162790697675	0.06781377720082077	2328, 2330, 2194, 2329	37	182	6921	4.111078111078111	0.8389095924500218	0.352631641444268	0.352631641444268
GOTERM_MF_DIRECT	GO:0030021~extracellular matrix structural constituent conferring compression resistance	2	2.3255813953488373	0.06808241537783673	2331, 4060	84	16	18883	28.09970238095238	0.9999999855242292	0.5126205393154766	0.4805817556082592
WIKIPATHWAYS	WP558:Complement and coagulation cascades	3	3.488372093023256	0.06981105859507773	730, 2244, 5648	64	58	8414	6.8001077586206895	0.9999996879439408	0.4128825465480312	0.37697971641341976
GAD_DISEASE	longevity	6	6.976744186046512	0.07081534923968069	335, 2267, 2244, 348, 338, 5105	76	382	12924	2.6709837420777074	1.0	0.5260006774080727	0.48941274696757103
GOTERM_CC_DIRECT	GO:0005796~Golgi lumen	3	3.488372093023256	0.0712726651122585	2331, 2719, 4060	85	107	20521	6.76888400219901	0.9999629681433401	0.2732118829303242	0.22965636536172182
GOTERM_BP_DIRECT	GO:0055089~fatty acid homeostasis	2	2.3255813953488373	0.07165503749546062	348, 5424	85	17	19256	26.65190311418685	1.0	0.6086906869351234	0.5853085168050257
GOTERM_BP_DIRECT	GO:0055091~phospholipid homeostasis	2	2.3255813953488373	0.07165503749546062	9388, 335	85	17	19256	26.65190311418685	1.0	0.6086906869351234	0.5853085168050257
GOTERM_MF_DIRECT	GO:0008392~arachidonic acid epoxygenase activity	2	2.3255813953488373	0.07218212171641072	1558, 8529	84	17	18883	26.446778711484594	0.9999999953176851	0.5279606616971756	0.49496312034110207
GAD_DISEASE	gout	2	2.3255813953488373	0.07290203512166048	335, 348	76	13	12924	26.16194331983806	1.0	0.5355495657014289	0.4982974268755254
GAD_DISEASE	lipoproteins	2	2.3255813953488373	0.07290203512166048	335, 4018	76	13	12924	26.16194331983806	1.0	0.5355495657014289	0.4982974268755254
GAD_DISEASE	Carotid Artery Diseases	3	3.488372093023256	0.07359431211087744	348, 338, 4018	76	77	12924	6.625427204374572	1.0	0.5376808485914926	0.5002804604695713
GOTERM_BP_DIRECT	GO:0070374~positive regulation of ERK1 and ERK2 cascade	4	4.651162790697675	0.07466212407654163	2244, 2266, 348, 2243	85	224	19256	4.045378151260504	1.0	0.6171374645228419	0.5934308209042445
BIOCARTA	h_alternativePathway:Alternative Complement Pathway	2	2.3255813953488373	0.07518768389280292	730, 727	15	9	1623	24.044444444444444	0.7735259267938822	0.16917228875880658	0.12217998632580475
GOTERM_BP_DIRECT	GO:0022011~myelination in peripheral nervous system	2	2.3255813953488373	0.07570831349164975	56288, 1291	85	18	19256	25.17124183006536	1.0	0.6171374645228419	0.5934308209042445
GOTERM_BP_DIRECT	GO:0009395~phospholipid catabolic process	2	2.3255813953488373	0.07570831349164975	9388, 336	85	18	19256	25.17124183006536	1.0	0.6171374645228419	0.5934308209042445
GOTERM_BP_DIRECT	GO:0006103~2-oxoglutarate metabolic process	2	2.3255813953488373	0.07570831349164975	5264, 1291	85	18	19256	25.17124183006536	1.0	0.6171374645228419	0.5934308209042445
GAD_DISEASE	chronic obstructive pulmonary disease	6	6.976744186046512	0.07589709932880245	336, 348, 338, 635, 5424, 5648	76	390	12924	2.6161943319838055	1.0	0.5514914228402656	0.5131303889403819
GOTERM_MF_DIRECT	GO:0042802~identical protein binding	13	15.11627906976744	0.07608954543144718	122622, 3437, 1610, 3248, 2335, 335, 27232, 3158, 2266, 348, 5648, 2705, 32	84	1734	18883	1.6853339374965675	0.9999999984105399	0.5410812119569577	0.5072636362096479
GAD_DISEASE	Obesity	4	4.651162790697675	0.07712659297703758	336, 348, 338, 4018	76	171	12924	3.977839335180055	1.0	0.5573959719475635	0.5186242252077554
UP_SEQ_FEATURE	CARBOHYD:C-linked (Man) tryptophan	2	2.3255813953488373	0.07774387352898054	7057, 730	84	20	20562	24.478571428571428	1.0	1.0	0.9982174688057041
REACTOME_PATHWAY	R-HSA-8957322~Metabolism of steroids	4	4.651162790697675	0.07774700605229984	5641, 3422, 2194, 32	72	155	11044	3.9584229390681003	0.9999999999999992	0.3714579178054326	0.3317205591564793
UP_KW_BIOLOGICAL_PROCESS	KW-0130~Cell adhesion	6	6.976744186046512	0.07792405808568705	7057, 3959, 2335, 4059, 1291, 83706	54	495	11447	2.5694725028058363	0.9901892687020893	0.28570384326444076	0.23056801386253115
GAD_DISEASE	warfarin response	2	2.3255813953488373	0.0782875472710506	348, 8529	76	14	12924	24.293233082706767	1.0	0.5623348721985219	0.5232195819109657
KEGG_PATHWAY	hsa00010:Glycolysis / Gluconeogenesis	3	3.488372093023256	0.07835425788601229	5232, 55902, 5105	61	67	8662	6.358208955223881	0.9999628034525974	0.6529521490501025	0.6268340630880983
GOTERM_BP_DIRECT	GO:0050821~protein stabilization	4	4.651162790697675	0.07859964511180659	10437, 57733, 335, 336	85	229	19256	3.9570511173901877	1.0	0.6258918489541907	0.6018489154751574
GAD_DISEASE	lung cancer 	7	8.13953488372093	0.07865117509433328	1558, 336, 348, 635, 5424, 5648, 383	76	516	12924	2.3069155446756424	1.0	0.5623348721985219	0.5232195819109657
INTERPRO	IPR008930:Terpenoid_cyclase/PrenylTrfase	2	2.3255813953488373	0.07939218619919854	727, 5858	86	20	20603	23.956976744186047	0.9999999999999228	0.9659382654235822	0.9474134219771025
GOTERM_BP_DIRECT	GO:0046889~positive regulation of lipid biosynthetic process	2	2.3255813953488373	0.07974410211877293	348, 5105	85	19	19256	23.846439628482972	1.0	0.6258918489541907	0.6018489154751574
GOTERM_BP_DIRECT	GO:0050995~negative regulation of lipid catabolic process	2	2.3255813953488373	0.07974410211877293	341, 336	85	19	19256	23.846439628482972	1.0	0.6258918489541907	0.6018489154751574
UP_KW_BIOLOGICAL_PROCESS	KW-0204~Cytolysis	2	2.3255813953488373	0.08019757003914127	730, 727	54	18	11447	23.55349794238683	0.9914770587151559	0.28570384326444076	0.23056801386253115
GAD_DISEASE	Hearing Loss	3	3.488372093023256	0.08031141085646284	2328, 2330, 2329	76	81	12924	6.298245614035087	1.0	0.5711508314632491	0.5314223143906371
REACTOME_PATHWAY	R-HSA-1679131~Trafficking and processing of endosomal TLR	2	2.3255813953488373	0.08046790049750867	1514, 5641	72	13	11044	23.598290598290596	0.9999999999999998	0.3802329364167992	0.33955685484663
GOTERM_BP_DIRECT	GO:0045087~innate immune response	6	6.976744186046512	0.08092249984016545	730, 2244, 2243, 727, 3669, 383	85	528	19256	2.574331550802139	1.0	0.6258918489541907	0.6018489154751574
GOTERM_MF_DIRECT	GO:0004867~serine-type endopeptidase inhibitor activity	3	3.488372093023256	0.08184164412421087	5176, 3698, 5858	84	108	18883	6.244378306878307	0.9999999996787055	0.5564685485601166	0.5216892642751093
GOTERM_MF_DIRECT	GO:0019899~enzyme binding	5	5.813953488372093	0.08260080017689231	335, 336, 348, 5424, 116519	84	374	18883	3.0053157626687037	0.9999999997400203	0.5564685485601166	0.5216892642751093
GOTERM_BP_DIRECT	GO:0051607~defense response to virus	4	4.651162790697675	0.0834429404733798	3437, 3434, 3433, 3669	85	235	19256	3.856020025031289	1.0	0.6258918489541907	0.6018489154751574
GAD_DISEASE	myocardial infarct; cholesterol, HDL; triglycerides; atherosclerosis, coronary; macular degeneration; colorectal cancer	2	2.3255813953488373	0.08364218971328718	348, 338	76	15	12924	22.673684210526318	1.0	0.5854953279930103	0.5447690261954411
GAD_DISEASE	Dyslipidemias|Hypertriglyceridemia	2	2.3255813953488373	0.08364218971328718	338, 116519	76	15	12924	22.673684210526318	1.0	0.5854953279930103	0.5447690261954411
GAD_DISEASE	atherosclerosis, carotid	2	2.3255813953488373	0.08364218971328718	335, 116519	76	15	12924	22.673684210526318	1.0	0.5854953279930103	0.5447690261954411
GOTERM_BP_DIRECT	GO:0045807~positive regulation of endocytosis	2	2.3255813953488373	0.08376247792695489	348, 2719	85	20	19256	22.654117647058825	1.0	0.6258918489541907	0.6018489154751574
GOTERM_BP_DIRECT	GO:0031638~zymogen activation	2	2.3255813953488373	0.08376247792695489	1514, 5648	85	20	19256	22.654117647058825	1.0	0.6258918489541907	0.6018489154751574
GOTERM_BP_DIRECT	GO:0019373~epoxygenase P450 pathway	2	2.3255813953488373	0.08376247792695489	1558, 8529	85	20	19256	22.654117647058825	1.0	0.6258918489541907	0.6018489154751574
GOTERM_BP_DIRECT	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	2	2.3255813953488373	0.08376247792695489	143941, 56288	85	20	19256	22.654117647058825	1.0	0.6258918489541907	0.6018489154751574
GOTERM_BP_DIRECT	GO:0007229~integrin-mediated signaling pathway	3	3.488372093023256	0.08466680305079222	2335, 335, 83706	85	111	19256	6.122734499205087	1.0	0.626845046440269	0.6027654969487592
SMART	SM00179:EGF_CA	3	3.488372093023256	0.08558315223419372	7057, 4148, 5648	40	134	10690	5.983208955223881	0.9957361946618433	0.5800635873650908	0.5705543482279581
GOTERM_CC_DIRECT	GO:0009897~external side of plasma membrane	5	5.813953488372093	0.08581202693039935	7057, 2244, 2266, 2243, 4059	85	407	20521	2.965891024714554	0.9999958033816116	0.3200556680106787	0.26903230064665745
WIKIPATHWAYS	WP4583:Biomarkers for urea cycle disorders	2	2.3255813953488373	0.08629502660871234	2628, 383	64	12	8414	21.911458333333336	0.9999999922938104	0.48278568940549876	0.4408043251093684
WIKIPATHWAYS	WP5148:Complement mediated inflammation of pulmonary alveolus in COVID 19 hypothetical pathway 	2	2.3255813953488373	0.08629502660871234	730, 727	64	12	8414	21.911458333333336	0.9999999922938104	0.48278568940549876	0.4408043251093684
GOTERM_BP_DIRECT	GO:0045088~regulation of innate immune response	2	2.3255813953488373	0.08776351513935461	348, 26007	85	21	19256	21.575350140056024	1.0	0.6438650610678106	0.6191317068012653
GOTERM_MF_DIRECT	GO:0002020~protease binding	3	3.488372093023256	0.08840317790674823	7057, 2335, 5858	84	113	18883	5.968078381795196	0.9999999999487709	0.5802875267725012	0.54401955634922
GOTERM_BP_DIRECT	GO:0006656~phosphatidylcholine biosynthetic process	2	2.3255813953488373	0.09174728767839618	335, 336	85	22	19256	20.59465240641711	1.0	0.6670275779861776	0.6414044616075264
WIKIPATHWAYS	WP4292:Methionine metabolism leading to sulfur amino acids and related disorders	2	2.3255813953488373	0.09314618268236856	27232, 635	64	13	8414	20.22596153846154	0.9999999983773753	0.507401574085534	0.46327969807809627
GAD_DISEASE	Fatty Liver	2	2.3255813953488373	0.09425956278100545	348, 5858	76	17	12924	20.006191950464398	1.0	0.656380392907314	0.6107234171852645
KEGG_PATHWAY	hsa01230:Biosynthesis of amino acids	3	3.488372093023256	0.09499936829325498	5053, 5232, 383	61	75	8662	5.68	0.9999961883738848	0.7421825647910545	0.7124952621994123
GOTERM_BP_DIRECT	GO:0001822~kidney development	3	3.488372093023256	0.09526135406815701	5176, 3248, 3158	85	119	19256	5.711122095897182	1.0	0.6775534420920697	0.6515259864478886
GOTERM_BP_DIRECT	GO:0048260~positive regulation of receptor-mediated endocytosis	2	2.3255813953488373	0.09571386914311766	7018, 116519	85	23	19256	19.69923273657289	1.0	0.6775534420920697	0.6515259864478886
GOTERM_BP_DIRECT	GO:0042178~xenobiotic catabolic process	2	2.3255813953488373	0.09571386914311766	1558, 2329	85	23	19256	19.69923273657289	1.0	0.6775534420920697	0.6515259864478886
GAD_DISEASE	Migraine Disorders	3	3.488372093023256	0.09607675743001123	10404, 2244, 727	76	90	12924	5.668421052631579	1.0	0.665568003543653	0.6192719494452538
UP_KW_BIOLOGICAL_PROCESS	KW-0152~Cholesterol biosynthesis	2	2.3255813953488373	0.09714315952189	3158, 3422	54	22	11447	19.27104377104377	0.9970469085883364	0.3257152995733959	0.26285796105923176
UP_KW_MOLECULAR_FUNCTION	KW-0210~Decarboxylase	2	2.3255813953488373	0.09887512405469094	130013, 5105	57	22	11872	18.934609250398722	0.9738498456848412	0.3845143713237981	0.3405698717439355
UP_KW_DOMAIN	KW-0245~EGF-like domain	4	4.651162790697675	0.09938134735360243	7057, 730, 4148, 5648	64	257	14600	3.5505836575875485	0.8126494390437236	0.5300338525525463	0.5300338525525463